The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACIC.L Regulatory News (ACIC)

  • There is currently no data for ACIC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

14 Feb 2023 07:00

RNS Number : 7894P
abrdn China Investment Company Ltd.
14 February 2023
 

 

abrdn China InvestmentCompany Limited

LEI: 213800RIA1NX8DP4P938

 

Seeking long-term capital growth by investing predominantly in Chinese equities

 

 

Annual Report

31 October 2022

 

Visit our Website

To find out more about abrdn China Investment Company Limited, please visit abrdnchina.co.uk

 

abrdn China Investment Company Limited is a closed-end investment company with its Ordinary shares listed on the Premium Segment of the London Stock Exchange.

The Company's name, objective and investment policy were changed following approval by shareholders at an Extraordinary General Meeting on 26 October 2021, and in November 2021 the Company completed its combination with Aberdeen New Thai Investment Trust PLC.

The Company seeks to produce long-term capital growth by investing predominantly in Chinese equities.

 

 

Financial Information

 

 

Financial Position as at 31 October 2022

NAV per Ordinary share2

Ordinary share price - mid market

Discount3

512.0p

448.0p

12.5%

2021

813.2p

2021

695.0p

2021

14.5%

 

 

 

 

 

Net Assets

 

Gearing - Net (cash) / debt3

 

Dividend yield

£231.8m

-3.6%

0.7%

2021

£373.8m

2021

-70.0%

2021

2.5%

Performance for the Financial Year ended 31 October 2022

Net asset value ("NAV") perOrdinary share total return1,3,4

 

Ordinary share price total return1,3,4

 

MSCI China All Shares Index NetTotal Return in sterling terms

-37.0%

-35.5%

-31.5%

2021

19.8%

2021

18.7%

2021

10.7%

 

 

 

 

 

Revenue return per Ordinary share

 

Ongoing charges ratio ('OCR')3

 

Dividend per Ordinary share declaredin respect of the Financial Year

4.0p

0.60%

3.2p

2021

-0.61p

2021

0.98%

2021

17.25p

1 Performance figures stated above include reinvestment of dividends on the ex-date.

2 See note 14 in the Notes to these Financial Statements for basis of calculation.

3 Definitions of these Alternative Performance Measures ('APMs') together with how these have been calculated can be found further below.

4 The Company's 2021 performance was attributable to the fund being managed in accordance with its previous investment objective, which was to achieve consistent returns for shareholders in excess of the MSCI Emerging Markets Net Total Return Index in sterling terms and the new investment objective, following approval by shareholders at the EGM on 26 October 2021, which is to produce long-term capital growth by investing predominantly in Chinese equities.

 

Financial Calendar

 

 

"October 2022 marked the first anniversary of our shareholders approving the Company's change of mandate, shifting from investing in a wide range of emerging market funds to concentrating on the compelling opportunities offered by Chinese equities. While this first Financial Year has seen some extremely challenging conditions, the Board believes that the long-term growth prospects for Chinese companies, which drove our proposal to change the Company's mandate, remain as compelling as ever. The performance of the portfolio and Chinese equity markets since the end of the Financial Year would appear to bear this out."

Financial Calendar

Online Shareholder Presentation

30 March 2023

Annual General Meeting ("AGM") (London)

13 April 2023

Half year end

30 April 2023

Announcement ofHalf-Yearly Financial Report for the six months ending 30 April 2023

June 2023

Financial year end

31 October 2023

Announcement of Annual Report and Accounts for the year ending 31 October 2023

January / February 2024

 

Helen Green, Chairman

 

 

 

 

Chairman's Statement

 

 

Overview

It is my pleasure to report to you for the first time as Chairman of the Board in what has been a hugely significant financial year to 31 October 2022 (the "Financial Year") for abrdn China Investment Company Limited ("the Company" or "ACIC").

October 2022 marked the first anniversary of our shareholders approving the Company's change of mandate, shifting from investing in a wide range of emerging market funds to concentrating on the compelling opportunities offered by Chinese equities. While this first Financial Year has seen some extremely challenging conditions, the Board believes that the long-term growth prospects for Chinese companies, which drove our proposal to change the Company's mandate, remain as compelling as ever. The performance of the portfolio and Chinese equity markets since the end of the Financial Year would appear to bear this out.

In his last report to shareholders, my predecessor, Mark Hadsley-Chaplin who retired on 1 August 2022, commented that investors in Chinese equities were largely ignoring company fundamentals, with share prices being heavily influenced by macroeconomic and geopolitical risks. This trend continued during the Financial Year and led to a general rotation from growth to value stocks, forcing share prices downwards. The Company's net asset value (NAV) total return for the Financial Year was -37.0%, while the share price total return was -35.5%. This compares with the total return of the MSCI China All Shares Index of -31.5% in Sterling terms. However, since the end of the Financial Year, the China re-opening trade has been positive and markets have rallied significantly.

There were a number of macro geopolitical and economic factors which had a significant negative influence on the performance of Chinese equities during the Financial Year- war in Ukraine, an energy crisis, soaring commodity prices and global inflation, which led to rising interest rates and fears of a worldwide recession. The ongoing tensions with the US, and the performance of the US dollar, compounded the challenges for Chinese equities. Markets continue to be extremely sensitive to any flare-ups between the two economic superpowers. Consequently, verbal sparring over Taiwan, the delisting of Chinese American Depositary Receipts (ADRs) and potential sanctions (such as the Biden administration's block on sales of American semiconductors to China announced in October) all added to volatility in Chinese stock markets.

Locally, three major domestic factors negatively affected share prices during the Financial Year: firstly, China's continued

 

commitment to its zero-Covid policy, which limited the reopening of the local economy; secondly, the travails of the country's heavily indebted real estate sector; and, thirdly, reaction to General Secretary Xi Jinping securing an unprecedented third term as China's leader at the 20th Communist Party Congress.

The Company's underperformance during the Financial Year should be considered against the challenging market backdrop.

ACIC's lack of exposure to energy companies hindered performance. Energy was the only sector at a market level to rise during the Financial Year, led by the surge in oil and gas prices. However, with the Chinese energy sector dominated by state-owned oil and gas companies, ACIC's Investment Manager believes it is difficult to find quality companies in this sector that will perform well over the long-term.

Stock selection in the financial sector also weighed on returns, as a number of the Company's bank holdings underperformed.

On a brighter note, there was positive news from some of ACIC's consumer holdings, which benefited from increased consumption of domestic brands over imported goods.

ACIC's Investment Manager responded to the challenging conditions during the Financial Year to mitigate short-term volatility. One such step was to reduce the underweight gap in value stocks, as the market style rotated from growth to value, adding to our holdings in more defensive sectors, while still maintaining exposure to the portfolio's five core themes: aspiration, digitalisation, going green, health and wealth. These are set out in more detail in the Investment Manager's Report, along with additional commentary on portfolio performance and activity.

Dividends

During the Financial Year, the Board revised ACIC's dividend policy so that a sufficient proportion of income delivered by the portfolio is paid out in dividends to Shareholders, thus enabling the Company to maintain its investment trust status.

At the end of the Financial Year, the revenue and profitability of the Company was such that the Board is declaring an interim dividend in respect of the Financial Year ended 31 October 2022 of 3.2p per Ordinary share which will be payable to Shareholders on 17 March 2023 with an associated ex-dividend date of 23 February 2023.

Loan Facility and Gearing

On 13 April 2022, the Company signed an agreement with the Industrial and Commercial Bank of China (ICBC) for a

 

 

 

new two year revolving credit facility. The facility provides ACIC with £15 million of borrowings, along with an option to increase the level of the commitment by a further £15 million, drawable in Sterling or Chinese Yuan.

At the Financial Year end the facility was unused. However, in December 2022 and late January 2023, the Investment Manager drew down CNH 106m (£12.7m) in two tranches. These funds provide the investment team with additional capacity to purchase quality, high conviction target companies and to fund investment in markets to which the Company gained access as part of its Qualified Foreign Investor licence.

Discount and buy backs

During the Financial Year, the Board closely monitored the Company's share price discount to NAV. The Board's intention is that ACIC's shares should not trade at a price which, on average, represents a discount that is out of line with its direct peer group over the long-term.

The Board seeks authority from Shareholders annually to buy back shares to assist the management of the discount.

Shares may be repurchased when, in the opinion of the Board, and taking into account factors such as market conditions and the discounts of comparable companies, the Company's discount is out of line with ACIC's direct peers and shares are available to purchase in the market. The Board believes that the principal purpose of share repurchases is to enhance the NAV for remaining shareholders, although it may also assist in addressing the imbalance between the supply of and demand ACIC's shares and thereby reduce the scale and volatility of the discount at which the shares trade in relation to the underlying NAV.

At the beginning of the Financial Year, and as part of the merger with Aberdeen New Thai Investment Trust plc (New Thai), the Company invited all shareholders to participate in a tender offer pursuant to which the Company would buy back up to 15% of the Ordinary shares in issue at a 2% discount to NAV. Shareholders tendered 6,894,773 Ordinary shares in response to the offer and the Company bought back those shares into treasury at a price of 801.92p per share. Simultaneously, the Company issued 7,554,440 new Ordinary shares to the shareholders of New Thai who had elected to roll their shareholding into ACIC. Following the completion of the Scheme of Arrangement on 9 November 2021, the number of Ordinary shares in issue was 46,624,826.

 

Between 9 November 2021 and 31 October 2022, ACIC bought back 1,341,251 shares or 2.9% of the share capital in issue at a cost of £7.55 million and a weighted average discount of 12.6%. This enhanced the Company's NAV by 0.35%. Since the Financial Year end, the Company has bought back a further 1,268,709 shares or 2.8% of the share capital in issue at the Financial Year end at a cost of £7.0 million and a weighted average discount of 14.4%. This enhanced the Company's NAV by 0.4%.

Investment Trust status

Following the merger with New Thai, the Board was pleased to announce that ACIC had been granted approval by HMRC to be classified as an investment trust under Chapter 4 of Part 24 CTA 2010 and Chapter 1 of Part 2 of The Investment Trust Tax Regulations. As a result, the Company became an investment trust with effect from 9 November 2021 and is registered in the United Kingdom for tax purposes. This means that, in respect of each accounting period for which ACIC is approved by HMRC as an investment trust, ACIC will be exempt from UK taxation on its chargeable gains. Income arising from overseas investments is subject to foreign withholding taxes at varying rates, however, like other investment trusts, the Company seeks to make use of double taxation relief where available. The Company is still liable to pay UK corporation tax on its net income in the normal way but should, in practice, be exempt from UK corporation tax on dividend income received, provided that such dividends (whether from UK or non-UK companies) fall within one of the "exempt classes" in Part 9A of the Corporation Tax Act 2009.

Qualified Foreign Investor approval

On 19 December 2022, ACIC announced that it had completed the process and had received regulatory approval for a Qualified Foreign Investor ("QFI") licence. The QFI scheme provides the Company with access to a broader investible universe of Chinese equities, including access to stocks listed on the Shanghai Stock Exchange STAR Market ("STAR"), and at the same time grants the Company more flexibility to trade onshore equities approaching Foreign Ownership Limits under the Stock Connect programme.

Management Team

Following the change of the Company's investment mandate, Nicholas Yeo and Elizabeth Kwik were appointed to lead ACIC's Investment Management Team on 26 October 2021. They manage ACIC's portfolio from Hong Kong and Shanghai, where the 13 strong Chinese equities team is based. The Board met members of the team, virtually, prior to appointment and was impressed by them and their track record.

 

 

 

 

 

 

On the change of the Company's investment mandate, Bernard Moody and Andrew Lister ceased to be involved in the day-to-day running of the portfolio. On behalf of the Board, I would like to thank Bernard, Andrew and the abrdn Closed End Fund Strategies team who have done an excellent job of managing the Company's portfolio.

The change of mandate and management team was not in any way a reflection of the service that they provided, and the Board and I wish them the very best.

Change of Company Secretary, Administrator, Depositary and Custodian

 

Following the end of the Financial Year, ACIC has signed agreements with abrdn plc and various entities within BNP Paribas S.A. ("BNPP") to take on various functions in due course. BNPP will become ACIC's administrator and provide custody and depositary services. abrdn will take on Company Secretarial responsibilities. An announcement will be made when the transfer process has been completed.

Board Composition

There have been some significant changes to the Board during the Financial Year.

Anne Gilding and Sarah MacAulay joined the Board as Directors in November 2021, both of whom had previously been directors of New Thai.

William Collins retired as a Director of the Company on 12 April 2022, having served on the Board for ten years, and Mark Hadsley-Chaplin retired as Chairman and a Director on 1 August 2022, having served for more than nine years. On behalf of the Board, I would like to record my thanks to them both, and particularly Mark for his efforts in steering the Company through its change of mandate.

I was honoured to be asked by my other Board colleagues to assume the role of Chairman on 1 August 2022 when the Board also appointed Sarah MacAulay as Senior Independent Director.

Lastly, the Board welcomed Mark Bridgeman to the Board on 1 August 2022 and as my successor as Chairman of the Audit Committee. Mark brings a wealth of experience in the investment sector. He will stand for election to the Board at the AGM in April 2023.

 

ACIC's Board takes its responsibilities very seriously, and regularly considers succession planning, and I am delighted to be working with the refreshed Board and look forward to building upon our successes.

The Board is developing plans to visit China, and the investment team in 2023, and I hope to be able to report on a successful trip in the next Annual Report.

Online Investor Presentation

In order to encourage as much interaction as possible with our shareholders, I will be hosting an Online Investor Presentation at 11:00am on Thursday, 30 March 2023. At this event, there will also be an update from Elizabeth Kwik, Portfolio Manager, followed by an opportunity to ask live questions of Elizabeth and me. The online presentation is being held ahead of the AGM to allow shareholder sufficient time to submit their proxy votes after the presentation but prior to the AGM should they so wish. Full details on how to register for the online event can be found on ACIC's website abrdnchina.co.uk.

Annual General Meeting ("AGM")

The Company's AGM will be held at 12 noon on 13 April 2023 at Wallacespace Spitalfields, 15-25 Artillery Lane, London, E1 7HA. The Board is delighted that Elizabeth Kwik will be travelling from Hong Kong to present an update on ACIC and meet with shareholders in person at the AGM and we encourage shareholders to attend.

In advance of the AGM, we would request that you complete and return the proxy form enclosed with the Annual Report so as to ensure that your votes are represented at the meeting. If you hold your shares in the Company via a share plan or a platform and would like to attend and/or vote at the AGM, you will need to make arrangements with the administrator of your share plan or platform. For this purpose, investors who hold their shares in the Company via the abrdn Investments Plan for Children, Share Plan or ISA will find a Letter of Direction enclosed. Shareholders are encouraged to complete and return the Letter of Direction in accordance with the instructions. The Notice of the Meeting is contained in the Annual Report for the Financial Year ended 31 October 2022.

Outlook

The last 12 months have been particularly challenging for investors in Chinese equities. We saw the Hang Seng Index in Hong Kong bottom out below 15,000, touching levels not seen since the aftermath of the Global Financial Crisis in 2008. Markets reacted positively to the announcements of the easing

 

 

 

 

 

of Covid restrictions in China to the point where the NAV Total Return of the Company in the first three months of the current financial year was almost 40%. This is, admittedly, following the heavily negative numbers, but it does highlight how much interest there is in China, interest that we believe is well-founded. The Board remains confident that any short-term headwinds that we may encounter in future will be strongly outweighed by long-term positive fundamentals and the compelling opportunities to invest in quality Chinese companies.

We consider that the actions that the Chinese government has taken in the last three months should not be seen as temporary and that, even if the uptick in domestic travel over Chinese New Year does lead to an increase in the number of people falling ill, there is little appetite for further draconian lockdowns such as we witnessed in late 2022, culminating in the tragic fire in Xinjiang. The return to the long-term trends of rising levels of urbanisation and the increase in the disposable incomes that the ever-expanding middle classes are able to deploy provides a ready market for high-quality goods and services.

The Board believes the portfolio is well positioned to capture China's long-term growth potential and is pleased to note the recent performance of the Chinese equities market since the end of the Financial Year. With a focus on these core themes, ACIC's Board believes that the portfolio comprises high-quality companies representing the finest structural growth opportunities in China, and arguably some of the most attractive areas of growth available anywhere to investors.

Helen Green

Chairman13 February 2023

 

 

 

 

 

 

 

 

 

Strategic Report

We see the brightest future for companies able to adapt to changing regulatory frameworks and align with policy objectives in areas such as digital innovation, green technology, access to affordable healthcare and improved livelihoods. We are focused on these themes that we believe will drive returns in 2023 and beyond.

 

Investment Manager's Report

 

Market Environment

At the start of the Financial Year, optimism towards Chinese stock markets was high. Facing rising inflation, Western economies were entering a tougher policy environment likely to hamper progress in their stock markets. Meanwhile, China stood out as a potential counter-cyclical recovery play, supported by the country's modest stock market valuations, low inflation rate and expansionary monetary policy.

Unfortunately, this optimism was not matched by the subsequent reality: the Company's Reference Index, the MSCI China All Shares Index, fell 31.5% in sterling terms over the Financial Year. Chinese stock markets endured an arduous period in what also proved to be a turbulent time for global financial markets and the world economy. However, unlike the major Western economies, buffeted by inflation and rising interest rates, China experienced a mixture of specific domestic and external challenges that caused its economy to stumble and its stock markets to fall heavily. These pressures were compounded by the difficult global economic backdrop.

Central to the country's domestic challenges was the Chinese government's zero-Covid policy. This strict approach to containment of the Covid-19 virus proved economically disruptive, as major cities were locked down to stop the spread of the virus. Recent months have seen an easing of restrictions and, crucially, increased efforts to boost vaccination rates and hospital capacity that should allow the country to start to reopen. At the time of writing, they have flocked to major airports, train stations and highways during the Lunar New Year holidays. We expect a multi-stage recovery in China where domestic consumption normalisation has a long runway ahead, supported by excess savings among households and depressed valuations.

Another domestic headwind came in the form of a slowdown in China's large and highly indebted property sector. The Chinese government's plans to reduce debt in the real estate sector should be positive in the long-term, resulting in a sector that is better regulated and less burdened by borrowing. The government is aware of the contagion risk from the real estate sector and has been providing liquidity to the property sector through targeted measures, while still having the overarching objective of reducing the sector's excessive leverage. Nevertheless, the short-term reaction - including the refusal of some citizens to pay their mortgages on properties they feared may never be built - was, at times, dramatic. The real estate crisis had a knock-on effect across sectors during the Financial Year, particularly affecting banks, which have a large proportion of mortgages on their books.

Some of the Company's bank holdings were among the worst detractors over the period. Furthermore, regulatory tightening in the technology and e-commerce sectors also hindered performance during the Financial Year.

Geopolitics also played a role in the country's weak stock market performance. Tensions with the US over key technologies and Taiwan, including a contentious visit by the US Speaker of the House of Representatives that saw China react with high-profile military drills, added to the list of issues facing Chinese investors.

Towards the end of the Financial Year, Chinese stock markets fell further after investors were disappointed by the outcome of October's 20th Communist Party Congress. Markets reacted warily to the strengthening of President Xi's position after his re-election, although they have since responded positively following the weakening of the previously announced continuation of the zero-Covid strategy.

Investment Themes

In constructing and managing the Company's portfolio, we employ a five-pronged thematic approach to identifying companies which we believe will deliver superior returns over the long-term. While this approach will not prevent us from buying into a position where we see fundamental value, we would expect most of the holdings to benefit from one of the themes below:

Aspiration: We expect consumer companies to fare well as China strives for a self-sufficient economic model.

Premiumisation - positioning goods and services as high-quality, in part to gain pricing power - is an ugly word but a powerful consumer trend. We believe urbanisation and rising middle-class wealth will drive demand for premium goods and services in the long-run.

Digital: This theme is aligned with the government's objectives of localisation, improving productivity, lowering costs, increasing innovation and helping to propel economic growth. Our holdings in this segment are primarily software-related names. Chinese companies have historically performed strongly given their knowledge of the domestic market and preference for localisation in areas such as cybersecurity and cloud services.

Green: This theme is set to benefit from government policy on decarbonisation and net-zero emissions by 2060. China dominates global manufacturing capacity for renewable energy and storage, accounting for 90% of solar and 75% of

 

 

 

 

 

battery capacity and is well positioned to benefit from the huge global investment required in renewable energy and electricity storage. Other industries also need to decarbonise, so we expect greater investment in upgrading machinery and increasing energy efficiency. Our holdings include solar wafer-producers, component-makers, battery and related component-makers and automation-related firms.

Health: This theme aligns with government policy objectives to make healthcare cheaper and more accessible. This is particularly relevant in view of China's rapidly ageing society. We are overweight in healthcare services, including companies providing innovative research and clinical trial services that seek to bring high-quality therapies to market.

Wealth: This theme aligns with the government's objective of China becoming a moderately prosperous society by 2035. The financial services sector plays a key role in creating and protecting wealth. Our holdings contribute to the creation of strong financial and capital markets, and also include software companies that support the development of capital markets, such as trading and portfolio management. The adoption of insurance services remains low in China relative to the rest of the world. We see a large potential market in terms of life and health insurance, especially given China's ageing population.

Portfolio Performance

During the Financial Year, the Company's net asset value ("NAV") total return was -37.0%, underperforming the total return of the Reference Index. The Ordinary share price total return was -35.5%, as the discount to NAV at which the Company's shares trade narrowed to 12.5% from 14.5% at the start of the Financial Year. The Company's shares are trading at an 13.5% discount at the time of writing.

In terms of broad headwinds for the portfolio, it was a year when macroeconomic and geopolitical concerns trumped bottom-up stock fundamentals. The many positive developments at the individual company level within the portfolio were often largely ignored by investors who were more concerned about bigger economic themes or threats. A rotation in investment style factors, which saw value stocks favoured over growth stocks, also posed a challenge.

The Company's NAV underperformance during the Financial Year was largely driven by stock selection. Sector allocation effects were broadly neutral, although the portfolio's lack of exposure to the strong-performing energy sector was a detractor to performance. We find few quality stocks in a

sector dominated by state-owned enterprises that we do not view as long-term structural winners. We own many renewable energy-related companies in the portfolio, but these are classified within the industrials sector.

Stock picking within financials accounted for almost half of overall underperformance, with banks being a particular area of weakness. Stock selection was also negative in the healthcare, and materials sectors, although our stock choices in information technology and consumer staples contributed positively to overall returns.

China Merchants Bank (CMB) was the portfolio's worst performing stock which suffered due to its property exposure, soft consumer confidence and an unexpected change in senior management.

In the consumer discretionary sector, China MeiDong Auto, a vehicle dealer, struggled against a backdrop of subdued global demand for high-end cars. Elsewhere, CIFI Ever Sunshine, a property management company, was affected by the broader weakness in the property sector. We exited the stock during the Financial Year.

On a brighter note, Proya Cosmetics (see case study below) was a strong contributor to performance. It grew its business over the Financial Year, navigating lockdown effects and expanding in cities considered to be "lower-tier" in the unofficial hierarchical classification of Chinese cities. Owning medical equipment-maker Shenzhen Mindray was also helpful. China's difficulties in dealing with the Covid-19 pandemic have highlighted the need to invest in domestic healthcare. Shenzhen Mindray also benefited from expectations of easing Covid-19 restrictions. Lastly, China Tourism Group Duty Free, the travel retailer, recovered in line with the easing of the burdensome international travel requirements in China.

Portfolio Activity

Our commitment to rigour in our investment process assumed even greater importance given the volatile market conditions and an uncertain economic environment. We mitigated short-term volatility at the portfolio level by adding to defensive sectors such as consumer staples and lowering active exposure to the healthcare, technology and renewable energy sectors.

We initiated a position in Inner Mongolia Yili, the dairy products producer, for its defensive fundamental characteristics. We also established a holding in Anhui Conch Cement, the largest cement manufacturer in China, to increase the portfolio's

 

 

 

 

 

exposure to infrastructure. In August, we participated in the Hong Kong IPO of China Tourism Group Duty Free. Its shares were listed at an attractive discount and we believe the company's long-term outlook is positive. Elsewhere, we continued to increase our position in Aier Eye Hospital Group, the provider of ophthalmology medical services, to reflect our preference for medical services companies within the healthcare sector.

We exited China Conch Venture, the construction engineering company, and its spin-off entity, China Conch Environment Protection, companies principally engaged in the provision of environmental protection services due to worsening competition dynamics and concern over the companies' funding capability. In September, we sold out of our position in surgical robot company Shanghai Microport Medbot due to increased regulatory risks that did not align with our original expectations.

We calculate that the average top line revenue growth of the companies in the portfolio during the Financial Year was 18% year-on-year ("yoy"). This growth was mainly driven by our holdings in the "Green" theme, which are expected to register an average of 61% yoy growth due to favourable government policies and accelerated developments throughout the industry. The "Health & Wellness" theme also performed well, with revenue growth of 22% yoy.

Our "Aspiration", "Digital" and "Wealth" themes performed less well, being negatively affected by Covid, delivering 12%, 12% and 2% yoy revenue growth respectively.

Earnings growth for the portfolio is largely in-line with revenue growth.

Looking ahead, we expect top line revenue to recover. Growth of Green investments is predicted to normalise from a high base this year, while growth from companies representing Aspiration, Wealth and Digital themes should gradually pick up as Covid subsides and the Chinese economy recovers post reopening. Earnings growth for the portfolio is expected to rebound to 65% yoy next year. Three Year Earnings Compound Annual Growth Rate ("CAGR") for holdings in the portfolio remains solid at 35% on average.

Outlook

While it is still early for the Chinese economy to show strong signs of recovery, we are positive on the outlook in 2023 for several reasons. Firstly, stimulus measures have been working their way through the system since the start of the second half

of 2022. Furthermore, we believe macro policy is likely to remain largely accommodative, with more legroom to support growth due to relatively low levels of inflation pressures that remain well contained. Secondly, recent measures to ease Covid restrictions have come at an accelerated pace that has taken everyone by surprise and this is a positive development for markets. It reflects the Government's concerns over the state of the economy as a result of its zero-Covid strategy. While the pivot may not seem gradual by international standards at the time of writing, there are still restrictions such as the need for a PCR test before entering China and, more importantly, the mandate requiring everyone to continue to wear masks. Like other Asian countries, we think the reopening will be bumpy with infections peaking in different phases, starting with cities before moving to rural areas.

Additionally, the troubled property sector now appears to be well-supported, including a raft of liquidity support measures announced in recent months. This indicates that the central Government is well aware of the economic headwinds facing China and is prepared to intervene and protect the growth trajectory. Chinese companies have thus far demonstrated strong fundamentals, with earnings growth of around 20%, despite an extremely challenging environment in the Chinese equities markets for most of the Financial Year. Valuations also remain undemanding due to investor sentiment. We believe a combination of favourable earnings and supportive policies in 2023 will help improve international investor sentiment towards China.

Given the rapid pace of reopening, inevitably, the number of deaths from Covid will rise, but it is a price the Government judges as not being high enough to offset the benefits of abandoning its zero-Covid strategy. However, the direction of travel for China is still one of reopening and economic recovery. To that end, we believe there is strong long-term potential in our five portfolio themes: aspiration, digital, green, health and wealth. That said, the long-term growth trajectory also faces some headwinds, including supply chain diversification away from China and restricted access to advanced US technologies. This is where we believe our bottom-up stock-picking approach, grounded in fundamental research and local expertise, provides an advantage in finding the best quality companies in which to invest.

Nicholas Yeo and Elizabeth Kwikabrdn Hong Kong Limited 13 February 2023

 

 

ESG Highlights for the Company

 

The Investment Manager has been actively integrating Environmental Social and Governance ("ESG") into its investment decision-making process for 30 years and believes that ESG factors are financially material, and can materially affect a company's performance.

Our Investment Manager has ESG resources and expertise in China, Hong Kong and Singapore. This enables our Investment Manager to glean insights from company visits, have a deep understanding of the relevant government policy developments and obtain an ESG information advantage.

The Company's portfolio is ESG BBB rated by MSCI. This is higher than the benchmark rating of BB.

The Company's carbon footprint is 52.8% lower than its benchmark.

Our Approach to ESG

Although ESG factors are not the over-riding criteria in relation to the investment decisions taken by our Investment Manager, significant emphasis is placed on ESG and climate-related factors throughout the Company's investment process.

The Board believes that a full and thorough assessment of ESG factors will result in better investment decisions to be made. ESG factors are considered by our investment manager, alongside financial and other fundamental factors, in order to make the best possible investment decisions at a stock picking and at a portfolio construction level.

Our approach to due diligence and research, coupled with third party provided research (including MSCI and abrdn's in-house ESG rating tools), enables us to identify ESG leaders and laggards. Our Investment Manager has a close relationship with the ESG specialists within abrdn. The type of ESG research and analysis required in China is deeper and more nuanced than for many other markets. There are two components to this:.

1. At the macroeconomic level, our Investment Manager works closely with the abrdn Research Institute to understand and contextualise economic, political and regulatory developments. Government policy objectives in China focus on areas such as social, economic and financial stability, climate change and national security. However, within these broader policy objectives, more granular objectives have emerged. These include protecting

personal data, tackling monopolistic practices and ensuring basic labour rights. These policy initiatives translate into investment insights. Companies that do not adapt to the developing policy focus may face a challenged outlook. As investors, understanding policy direction is key to assessing investment opportunities.

2. At the stock level, our Investment Manager works closely with abrdn's Central ESG Investment Function - a team of more than 20 ESG experts - to identify and understand material ESG risks and opportunities. This process focuses on rigorous due diligence and ESG analysis, coupled with ongoing engagement and dialogue, which helps our Investment Manager to identify and invest in companies with strong ESG standards. This process is research-intensive and requires a strong on-the-ground presence. However, our Investment Manager also believes that this attention is an important contributor to alpha generation, encouraging and investing in positive change at companies. Progressive ESG policies should drive a company's financial performance and share prices over the long-term. (For more on the link between ESG and performance, see: https://www.abrdn.com/en/ capgemini/insights-thinking-aloud/article-page/esg-performance-evidence)

External research agencies primarily use backward looking data to create ESG ratings and in doing so form the market view of a company's ESG credentials. Through our Investment Manager's fundamental research, the team forms a forward-looking view of companies' ESG credentials.

ACIC does not exclude any sectors from its investment universe but all investments must pass a quality test and ESG issues are only part of the investment analysis. In addition, our Investment Manager undertakes engagement initiatives with, well-managed and well-capitalised companies which may not necessarily immediately be considered ESG leaders. Our Investment Manager seeks to effect change and develop best ESG practice through these engagement activities, which often run over several years. Progressive, well-managed companies are usually open to engagement and expert advice.

ESG Considerations in China

There is a growing appreciation from many Chinese companies of the value that attention to ESG factors can bring. Standards are evolving, disclosure is improving, and regulations (and enforcement of those regulations) around some social and environmental behaviours are stronger than

 

 

 

 

 

in the past. Importantly, dialogue between companies and investors has improved significantly over the last five to ten years.

More Chinese companies are outlining their thinking on sustainability, aspirations to reduce their carbon footprints, and the frameworks they have in place to negate ESG-related risks. There has been tangible progress, including improvements in corporate governance, formalised dividend payout policies, improved transparency in reporting, and much-improved shareholder engagement.

These improvements have, in many cases, come as a result of sustained engagement and dialogue between long-term investors and companies.

Set out below are some of the most pressing ESG issues we consider when investing in Chinese companies and how we respond to them:

1. State control and state-owned enterprises

One misconception often held about China is that its economy is dominated by state-owned enterprises (SOEs). The reality is more nuanced. In the early days of the Chinese economic growth story SOEs did indeed dominate the economy (and hence stock markets). They were typically involved in heavier industries, including iron and steel, oil and gas. However, over time the balance has tilted towards private/entrepreneur-owned companies.

SOE reform in the late 1990s and early 2000s saw a reduction in the number of SOEs coupled with a decline in their share of economic activity, and a formalisation of the governance structure of these SOEs. Many of the remaining SOEs underwent reform, putting in place governance structures and management processes more familiar to investors in listed companies

Not all SOES are the same

It's important to recognise that not all SOEs are the same in terms of market orientation. Our Investment Manager's deep due diligence focuses on the structure of SOE ownership (which government entity owns the SOE and whether it's a regional or central organisation); the degree to which an SOE's strategy might be influenced or driven by government policy; strategies considered by management and how they have been executed; and remuneration or incentive schemes that are in place.

Understanding the difference in quality of these companies requires deep due diligence and engagement with their boards and managers.

2. Related-party transactions

Share ownership in China can be concentrated. In addition, controlling shareholders often have multiple private and public interests.

Complex ownership structures present challenges for investors. Perhaps the most difficult of these involve related-party transactions. These are transactions between a listed company and another connected party such as shareholders, directors, sister companies, suppliers, or a range of other potential parties.

There are very clear conflicts of interest here, and a risk that value is 'tunnelled' out of the listed company. This could be through mispricing on transactions, the provision of financial guarantees (or broader financial services), or the deprivation of business opportunities.

However, related party transactions are also part of the normal course of business in China. As investors, we need to be aware of the risks, and how best to manage them. This can involve identifying which transactions are a normal course of business, and which have the potential to be abusive and potentially negative to the long-term prospects of that company.

How our Investment Manager's Due Diligence process helps

Our Investment Manager's due diligence process always starts with the controlling shareholder in order to ascertain how their interests align with ACIC's interests as a minority shareholder. Our Investment Manager checks the controlling shareholder's background to understand the alignment of interests, what connections they retain to privately held vehicles, and the way these interests may compete. Attention is also given to the board and management team and their competence, character, and commitment and, ultimately, whether the management team meets the quality hurdle.

Our Investment Manager also examines transactions in detail to understand rationale and pricing and whether a transaction is in the normal course of business, why a particular counter-party was sought, and how pricing was determined. This is laborious work, but absolutely critical to your Company's investment approach.

 

 

3. Climate and environmental impact

China is both the largest single emitter of carbon dioxide globally, and also - by some distance - the world's top investor in renewable energy.

China has steadily funded research into renewables over the past decades, with the aim of both decarbonising its own energy system, and establishing itself as the 'winner' as the world seeks to decarbonise. China has set ambitious targets for decarbonisation, including its peak carbon and net-zero pledges.

This presents compelling investment opportunities. Not just in the context of the domestic Chinese market, but because Chinese renewables companies are worldleaders and will be central to decarbonisation globally.

Chinese companies are also increasingly conscious of their own environmental impact and carbon footprint. When conducting research, ACIC looks for companies that are either maximising their energy efficiency, minimising their carbon footprint, or providing products or services that allow other companies to do the same. We are able to get reliable data from companies. This is the starting point for engagement in order to understand how companies are managing their carbon emissions, water or energy risk and other factors.

While many Chinese companies are willing to disclose snapshot statistics (current year water consumption, for example), they tend to bes less willing to disclose targets publicly for fear of not achieving targets. However, many companies are doing a lot more than they disclose publicly.

Engagement and disclosure

Our approach is to engage collaboratively with portfolio companies, with the aim of sharing expectations and disclosure of best practices, to help maintain and enhance the ESG standards of these companies. These meetings provide an opportunity to discuss various relevant ESG issues including board composition, remuneration, audit, climate change, labour issues, human rights, bribery and corruption. Companies are strongly encouraged to set clear targets or key performance indicators on all material ESG risks so as to enable performance monitoring. Discussions cover both risk and opportunities; our Investment Manager challenges management teams constructively on issues relating to strategy and execution, as well as capital allocation and return. These engagements are collaborative and usually long-term.

Please see below for some specific examples of our Investment Manager's engagement and its outcome.

 

ESG case study: Proya Cosmetics

Proya Cosmetics ("Proya") is China's fifth largest beauty and skincare company. Proya has five brands, focused on younger consumers and is enjoying rapid sales growth through its online channels and boutiques. The company has invested in product upgrades and innovation, expanding beyond its traditional skin-care related products into colour cosmetics.

Our Investment Manager has engaged with Proya on several issues, including its use of certain chemicals in products, animial testing and sustainable packaging. Proya now closely follows China's strict environmental protection laws and regulations. It has also eliminated all non-degradable raw materials such as microbeads from its products, replacing them with natural degradable materials.

Up until October 2022, Proya was rated CCC rating by MSCI, and was considered an ESG "laggard". However, based on on-the-ground engagement, it was clear that the company's management was more advanced in its thinking and ESG practices than its disclosures suggested. Therefore, we encouraged management to improve disclosures.

As a result, MSCI has now upgraded the Proya's rating to BBB, which is considered an "average" rating and our Investment Manager expects this to advance further over time with the company's understanding of its ESG obligations and opportunities for further improvements.

 

 

 

ESG case study: Kweichow Moutai

Kweichow Moutai is a high-end Chinese producer of baijiu, the world's biggest-selling spirit.

Our Investment Manager has invested in Kweichow Moutai for a number of years. The company's products are hugely popular in China's massive baijiu market. Male consumers, who account for most baijiu consumption, tend to drink premium baijiu such as Kweichow Moutai as they grow older and wealthier. Swelling numbers of high-net-worth individuals in China should therefore be a powerful long-term driver of demand. We have actively engaged with the company on a range of topics including climate change, environmental practices, labour management, human rights and stakeholder interests and corporate governance.

We reviewed the company's 2019 corporate and social responsibility (CSR) report and believe that its ESG practices, and disclosures, have been improving. Meanwhile, Kweichow Moutai sought specific feedback from investors on a range of ESG-related topics. In January 2022, we contacted the Board to encourage the company to establish energy efficiency targets and distribute its CSR report to a wider audience.

MSCI recently upgraded the company's ESG rating from CCC to B. Our Investment Manager believes that its engagement with the company has contributed to, and will continue to contribute to, a higher ESG rating and positive outcomes for stakeholders.

 

 

Information about the Manager, Investment Manager and Investment Management Team

 

Manager (abrdn Fund Managers Limited)

The Company's Alternative Investment Fund Manager is abrdn Fund Managers Limited (previously know as Aberdeen Standard Fund Managers Limited) ("AFML" or the "Manager"), which is a wholly owned subsidiary of abrdn plc and is authorised and regulated by the FCA. AFML has been appointed to provide investment management, risk management and promotional activities to the Company.

The abrdn Group's assets under management and administration were £508 billion as at 30 June 2022, managed for a range of clients including 22 UK-listed closed end investment companies.

The Investment Management Team

Nicholas Yeo

Director and Head of Equities, China

Nicholas Yeo is the Head of China/Hong Kong Equities team at abrdn. Nicholas joined abrdn in 2000 via the acquisition of Murray Johnstone. He was seconded to the London Global Emerging Market team for two years where he covered EMEA and Latin American companies, before returning to the Asian Equities team in Singapore in March 2004. In March 2007, he transferred to Hong Kong to lead Chinese equity research.

Nicholas holds a BA (Hons) in Accounting and Finance from The University of Manchester and an MSc in Financial Mathematics from Warwick Business School. He is a CFA charterholder.

Investment Manager (abrdn Hong Kong Limited)

The Company's portfolio is managed by abrdn Hong Kong Limited ("aHKL") by way of a group delegation agreement in place between AFML and aHKL. aHKL is authorised and regulated by the Securities and Futures Commission of Hong Kong.

 

Elizabeth Kwik

Investment Manager

Elizabeth Kwik is an Investment Manager on the China/Hong Kong Equities Team at abrdn where she is responsible for researching the Consumer Discretionary, Automobiles & Components and Banking sectors. Elizabeth sits on the China A share and All China equity fund portfolio construction groups. She joined abrdn in 2013.

Elizabeth holds a Bachelor of Science in Economics from the London School of Economics. She is a CFA charterholder.

 

 

Portfolio

The Company's NAV total return for the Financial Year was -37.0%, which compares to MSCI China All Shares Index Net Total Return in sterling terms of -31.5% for the Financial Year.

 

Ten Largest Investments

 

 

 

 

 

Tencent (7.0%) An innovative leader in China's internet sector with a strong presence in fintech and cloud segments, backed by an entrenched social media and payment ecosystem.

 

 

Contemporary Amperex Technology (3.2%) The largest lithium battery maker in the world with leading technology and supply chain advantage, set to benefit from rise of electric vehicle and energy storage.

 

 

 

Kweichow Moutai (4.9%) The largest maker of Chinese alcohol spirit Baijiu, positioned in the ultrapremium space where there are few competitors. The company is well placed to capture rising domestic consumption trends in China.

 

 

 

China Tourism Group Duty Free (3.2%) China's largest duty-free operator that is well placed to benefit from supportive government policy and rising demand for duty-free cosmetics on the mainland.

 

 

 

Meituan (4.3%) A diversified online services platform with over 400 million users, offering services including food delivery, travel bookings and wedding planning. It is optimally placed to capture rising consumption in mainland China.

 

 

 

Bank of Ningbo (3.1%) A city bank focused on lending to small and medium enterprises in the affluent Ningbo-Zhejiang region. The bank has shown superior returns and asset quality over the years.

 

 

 

China Merchants Bank (3.9%) A best-in-class retail bank in China, offering diversified financial services with a solid track record and sound risk management practices in place.

 

 

 

JD.com (3.0%) An online retailer with an edge in its strong logistics network. The company has shown improving corporate governance and management quality over the years.

 

 

 

Alibaba Group (3.6%) The Chinese internet group is a leading global e-commerce company with leading platforms including Taobao and T-mall in the mainland. The company also has interests in logistics and media as well as cloud computing platforms and payments.

 

 

 

Ping An Bank (2.6%) One of the three main pillars of the Ping An Group, a reputable retail bank offering services in retail and corporate banking, including investment banking services with solid management track record.

% shows the percentage of net assets invested in each holding.

 

Investments

 

 

Portfolio listing as at 31 October 2022

Company

 

Industry (Sub-Sector)

 

Value (£'000)

 

Percentage of net assets (%)

Tencent Holdings Ltd

Interactive Media & Services

16,323

7.0

Kweichow Moutai Co Ltd

Beverages

11,435

4.9

Meituan

Internet & Direct Marketing Retail

9,882

4.3

China Merchants Bank Co Ltd

Banks

9,007

3.9

Alibaba Group Holding Ltd

Internet & Direct Marketing Retail

8,244

3.6

Contemporary Amperex Technology Co Ltd

Electrical Equipment

7,364

3.2

China Tourism Group Duty Free Corp Ltd

Banks

7,326

3.2

Bank of Ningbo Co Ltd

Banks

7,125

3.1

JD.com Inc

Internet & Direct Marketing Retail

6,918

3.0

Ping An Bank Co Ltd

Banks

6,035

2.6

Top ten investments

 

89,659

 

38.8

AIA Group Ltd

Insurance

6,027

2.6

Glodon Co Ltd

Software

5,134

2.2

Proya Cosmetics Co Ltd

Personal Products

5,106

2.2

Wanhua Chemical Group Co Ltd

Chemicals

5,044

2.2

LONGi Green Energy Technology Co Ltd

Semiconductors & Semiconductor Equipment

4,731

2.0

Shenzhen Mindray Bio-Medical Electronics Co Ltd

Textiles, Apparel & Luxury Goods

4,584

2.0

Sungrow Power Supply Co Ltd

Electrical Equipment

4,533

1.9

Nari Technology Co Ltd

Electrical Equipment

4,033

1.7

Yunnan Energy New Material Co, Ltd.

Containers and Packaging

3,873

1.7

Hundsun Technologies Inc

Software

3,871

1.7

Top twenty investments

 

136,595

 

59.0

Chacha Food Co Ltd

Food Products

3,771

1.6

Fuyao Glass Industry Group Co Ltd

Auto Components

3,714

1.6

NetEase Inc

Interactive Media & Services

3,607

1.6

Midea Group Co., Ltd.

Electrical Equipment

3,599

1.5

Hefei Meiya Optoelectronic Technology Inc

Machinery

3,584

1.5

Li Ning Co Ltd

Textiles, Apparel & Luxury Goods

3,531

1.5

Hong Kong Exchanges & Clearing Ltd

Capital Markets

3,415

1.5

Sinoma Science & Technology Co Ltd

Chemicals

3,414

1.5

Aier Eye Hospital Group Co Ltd

Health Care Providers & Services

3,319

1.4

Shanghai M&G Stationery Inc

Commercial Services & Supplies

3,241

1.4

Top thirty investments

 

171,790

 

74.1

Foshan Haitian Flavouring & Food Co Ltd

Food Products

3,159

1.4

Venustech Group Inc

Software

3,112

1.3

StarPower Semiconductor Ltd.

Semiconductors & Semiconductor Equipment

3,067

1.3

By-health Co Ltd

Personal Products

3,034

1.3

China Vanke Co Ltd

Banks

3,026

1.3

Shenzhou International Group Holdings Ltd

Textiles, Apparel & Luxury Goods

2,987

1.3

China Resources Land Limited

Real Estate Management & Development

2,934

1.3

Amoy Diagnostics Co Ltd

Biotechnology

2,830

1.2

Estun Automation Co., Ltd

Machinery

2,724

1.2

Hangzhou Tigermed Consulting Co Ltd

Life Sciences Tools & Services

2,606

1.1

Top forty investments

 

201,269

 

86.8

Wuxi Biologics Cayman Inc

Life Sciences Tools & Services

2,545

1.1

China Meidong Auto Holdings Ltd

Banks

2,449

1.1

Luxshare Precision Industry Co Ltd

Electronic Eqpt Instruments & Components

2,259

1.0

Inner Mongolia Yili Industrial Group Co Ltd

Beverages

2,231

1.0

Jiangsu Hengrui Medicine Co Ltd

Pharmaceuticals

2,211

0.9

Zhejiang Weixing New Building Materials Co., Ltd.

Plumbing Fixtures & Fittings

2,122

0.9

Anhui Conch Cement Company Limited

Construction and Materials

2,057

0.9

Maxscend Microelectronics Co Ltd

Electronic Eqpt Instruments & Components

1,835

0.8

Komodo Fund

Unit Trusts

1,319

0.6

Yantai China Pet Foods Co Ltd

Food Products

1,291

0.5

Top fifty investments

 

221,588

 

95.6

GDS Holdings Ltd

IT Services

1,056

0.4

Zai Lab Ltd

Biotechnology

961

0.4

Wuliangye Yibin Co Ltd

Beverages

459

0.2

Total investments

 

224,064

 

96.6

Cash plus other net current assets and liabilities

7,779

3.4

Net assets

 

231,843

 

100.0

 

 

 

Sector Breakdown as at 31 October 2022

Sector breakdown

%

Consumer Discretionary

21.4

Financials

14.4

Consumer Staples

13.6

Industrials

12.3

Information Technology

11.2

Communication Services

8.9

Health Care

8.5

Materials

6.4

Real Estate

2.7

Unit Trusts

0.6

Source: Datastream

 

 

Governance

The Company is committed to high standards of corporate governance and applies the principles identified in the UK Corporate Governance Code and the AIC Code of Corporate Governance.

All Directors are considered by the Board to be independent of the Company and the Manager and free of any material relationship with the Manager.

 

Directors' Report

 

 

The Directors of abrdn China Investment Company Limited ("the Company") present the report and financial statements for the Financial Year ended 31 October 2022.

Investment Objective and Investment Policy

A change of investment objective and investment policy was approved by shareholders on 26 October 2021. The new investment objective and investment policy is set out below:

Investment Objective

The Company's investment objective is to produce long-term capital growth by investing predominantly in Chinese equities.

Investment Policy

The Company invests in companies listed, incorporated or domiciled in the People's Republic of China ("China"), or companies that derive a significant proportion of their revenues or profits from China operations or have a significant proportion of their assets there. In furtherance of the investment policy, the portfolio will normally consist principally of quoted equity securities and depositary receipts although unlisted companies, fixed interest holdings or other non-equity investments may be held. Investments in unquoted companies will be made where the Investment Manager has a reasonable expectation that the company will seek a listing in the near future. The portfolio is actively managed and may be invested in companies of any size and in any sector.

The Company is expected to have an ESG rating equal to, or better than, the MSCI China All Shares Index and have meaningfully lower carbon intensity than the Index.

The portfolio is actively managed and the Company aims to outperform the MSCI China All Shares Index (in sterling terms). This index is used as a reference point for portfolio construction and as a basis for setting risk constraints, but does not incorporate any sustainability criteria. In order to achieve its objective, the Company will take positions whose weightings diverge from the index or invest in securities which are not included in the index. Investments may deviate significantly from the components of, and their respective weightings in, the MSCI China All Shares Index. Due to the active nature of the management process, the Company's performance profile may deviate significantly from that of the index.

The portfolio is expected normally to comprise between 30 and 60 securities (including any unlisted securities held) but may hold up to 100. No individual issuer will represent a greater weight in the portfolio than the lower of (i) 10% or (ii) its weight in the MSCI China All Shares Index (in sterling

terms) plus 5%, as measured at the time of investment. The maximum permitted exposure to a single group is 20% of the Company's total assets, as measured at the time of investment.

The Company may continue to hold certain illiquid assets which were acquired prior to adoption of this policy pending their orderly disposal. These assets are not expected to represent a significant proportion of the portfolio.

Risk Management

The Company will at all times be invested in several sectors. While there are no specific limits placed on exposure to any one particular sector, the Company will at all times invest and ensure that the portfolio is managed in a manner consistent with spreading investment risk.

The Company may invest in unquoted securities and/or securities with lock-up periods provided that such investments, in aggregate, are limited to 10% of the Company's net assets at the time any such investment is made.

With prior approval of the Board, the Company may use derivatives for the purposes of efficient portfolio management in order to reduce, transfer or eliminate investment risk in the Company's portfolio. Derivative instruments in which the Company may invest may include foreign exchange forwards, exchange-listed and over-the-counter options, futures, options on futures, swaps and similar instruments. The Company does not intend to enter into derivative or hedging transactions to mitigate against wholesale general currency or interest rate risk.

The Company may invest no more than 10% in aggregate of its gross asset value at the time of acquisition in other listed closed-ended investment funds, but this restriction will not apply to investments in such funds which themselves have stated investment policies to invest no more than 15% of their gross asset value in other closed-ended investment funds.

Gearing

The Company may employ gearing and may in aggregate, borrow amounts equalling up to 20% of gross asset value, although the Board expects that borrowings will typically not exceed 15% of gross asset value at the time of drawdown.

While it is intended that the Company will be fully invested in normal market conditions, the Company may hold cash on deposit or invest on a temporary basis in a range of cash equivalent instruments. There is no restriction on the amount of cash or cash-equivalent instruments that the Company may hold.

 

 

 

 

 

 

 

 

 

Principal Risks, Emerging Risks and Uncertainties

Together with the issues discussed in the Chairman's Statement and the Investment Manager's Report, the Board considers that the main risks and uncertainties faced by the Company fall into the following categories:

 

(i) Risks relating to the Company

The Company has no employees and the Directors have been appointed on a non-executive basis. The Company is therefore reliant upon the performance of third-party service providers for its executive functions and is exposed to the risk that misconduct by employees of those service providers, any failure by any service provider to carry out its obligations to the Company in accordance with the terms of its appointment, or the termination of those appointments could have an adverse effect on the portfolio and the Company's financial condition, results of operations and prospects, with a consequential adverse effect on the market value of its Ordinary shares.

 

(ii)  Risks relating to the investment policy

There can be no guarantee that the Company will achieve its investment objective or that investors will get back the full value of their investment.

The investments of the Company are subject to the risk of changes in market prices or macroeconomic factors. Any such changes could have an adverse effect on the value of the portfolio, the Company's financial condition, results of operations and prospects, with a consequential adverse effect on returns to shareholders and the market value of its Ordinary shares.

The Company's NAV is inherently sensitive to the performance of Chinese equity markets which could result in the Company's Ordinary shares trading at a discount or being less liquid.

The portfolio will be concentrated in a single country and will therefore be exposed to risks associated with geographical concentration, including being exposed to the fluctuations of a more limited geographical market and fewer currencies than a less concentrated portfolio.

The Company is exposed to particular economic, regulatory, political, geopolitical, environmental and taxation risks associated with investments in the People's Republic of China, which could have an adverse effect on the portfolio, the Company's financial condition, results of operations and prospects were they to materialise, with a consequential adverse effect on the market value of its Ordinary shares.

The Company is exposed to currency and foreign exchange risk as a result of holding investments denominated in currencies other than sterling which could have an adverse effect on the portfolio and the Company's financial condition, results of operations and prospects, with a consequential adverse effect on the market value of its Ordinary shares.

(iii) Risks relating to the Manager/Investment Manager

The success of the Company is dependent on the Alternative Investment Fund Manager ("AIFM") and the Investment Manager and their expertise, key personnel, and ability to source and advise appropriately on investments. As a result of this, the Company's portfolio, financial condition, results of operations, prospects and the value of the shares could be adversely affected by: competitive pressures on the AIFM or the Investment Manager's ability to source and make successful investments; any failure by the AIFM or the Investment Manager to carry out due diligence and obtain relevant information on prospective investments; or any loss of key personnel of the AIFM or the Investment Manager and any inability to recruit appropriate replacements in a timely fashion.

(iv) Risks relating to regulation, taxation and the Company's operating environment

The Covid-19 pandemic may adversely affect the performance of investee companies due to ongoing macroeconomic and market uncertainty, which may in turn adversely impact the Company's financial performance and prospects and the value of its portfolio.

Changes in the laws or regulations in Guernsey or the UK which govern the Company's and the Investment Manager's operations may have an adverse effect on the ability of the Company and the Manager / Investment Manager to carry on their respective businesses and any such changes could have an adverse effect on the portfolio and on the Company's financial condition, results of operations and prospects, with a consequential adverse effect on the market value of the Shares.

Management or mitigation of the above risks

The Company has a risk management process in place. This mechanism enables the Board to monitor the Company's spread of investments across several sectors. The Board receives and monitors reports from the Manager and the Administrator on a quarterly basis at the minimum.

(v)  Internal Risks

Poor allocation of the Company's assets by the Investment Manager, poor governance, compliance or administration, including poor controls over cyber security, could result in shareholders not making acceptable returns on their investment in the Company.

Management or mitigation of internal risks

The Board monitors the performance of the Manager and the other key service providers at regular Board meetings. The Manager provides reports to the Board on compliance matters and the Administrator provides reports to the Board on compliance and other administrative matters. The Board has established various committees to ensure that relevant governance matters are addressed by the Board.

The management or mitigation of internal risks is described in detail in the Corporate Governance Statement in the Annual Report for the Financial Year ended 31 October 2022.

(vi) Emerging Risks

Emerging risks are slow moving trends, innovations and shifts with potential consequence to a specific industry or sector in the long-term. They can include movements in: demographics, economics, society, technological innovations, national policy and governance. Long-term shifts in temperatures and weather patterns caused by human activity, primarily due to the burning of fossil fuels, or by natural phenomena may have a negative effect on ecological and socioeconomic wellbeing.

Management or mitigation of emerging risks

A risk management register and associated risk heat map, providing a visual reflection of the Company's identified and emerging risks have been established to monitor and mitigate risks to the Company, with both a risk pre mitigation and risk post mitigation score determined, depending on the impact of the risk combined with the probability of the risk occurring.

(vii) Failure to manage premium and/or discount

The Board's discount control policy is that the Company's shares should not trade at a price which, on average, represents a discount that is out of line with the Company's direct peer group. To assist the Board in taking action to deal with a material and sustained deviation in the Company's discount from its peer group, it seeks authority from Shareholders annually to buy back shares. Shares may be repurchased when, in the opinion of the Board and taking into account factors such as market conditions and the discounts of comparable companies, the Company's discount is higher than desired and shares are available to purchase in the market. The Board is of the view that the principal purpose of share repurchases is to enhance the net asset value ("NAV") for remaining shareholders, although it may also assist in addressing the imbalance between the supply of and demand for the Company's shares and thereby reduce the scale and volatility of the discount at which the shares trade in relation to the underlying NAV.

 

 

 

 

 

Statement of Directors' Responsibilities

 

In Respect of the Annual Report and Accounts

The Directors are responsible for preparing the Annual Report and Accounts in accordance with applicable law and regulations.

Guernsey company law requires the Directors to prepare financial statements for each financial year. The Directors have elected to prepare the financial statements in accordance with International Financial Reporting Standards as issued by the IASB and applicable law.

Under company law the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of its profit or loss for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and then apply them consistently;

make judgements and estimates that are reasonable, relevant and reliable;

state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements;

assess the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and

use the going concern basis of accounting unless they either intend to liquidate the Company or to cease operations or have no realistic alternative but to do so.

The Directors are responsible for keeping proper accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that its financial statements comply with the Companies (Guernsey) Law, 2008. They are responsible for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error, and have general responsibility for taking such steps as are reasonably open to them to safeguard the assets of the Company and to prevent and detect fraud and other irregularities.

The Directors are responsible for the maintenance and integrity of the corporate and financial information included on the Company's website (but not for the content of any information included on the website that has been prepared or issued by third parties). Legislation in Guernsey governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Disclosure of Information to the Auditor

The Directors who held office at the date of approval of the Directors' Report confirm that, so far as they are each aware, there is no relevant audit information of which the Company's auditor is unaware; and each Director has taken all the steps that they ought to have taken as a Director to make themselves aware of any relevant audit information and to establish that the Company's auditor is aware of that information.

Responsibility Statement of the Directors in Respect of the Annual Report

We confirm that to the best of our knowledge:

the financial statements, prepared in accordance with the applicable set of accounting standards, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company; and

the Management Report (comprising the Chairman's Statement, the Investment Manager's Report and the Governance reports including the Directors' Report) includes a fair review of the development and performance of the business and the position of the Company, together with a description of the principal risks and uncertainties that it faces.

The Board considers that the Annual Report and Accounts, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to assess the Company's position and performance, business model and strategy.

Helen Green

Chairman

13 February 2023

 

 

 

 

Financial Statements

Net assets per Ordinary share decreased by 37.0% to 512.0p, while the revenue profit was 4.0p per Ordinary share as compared to a loss of 0.61p per Ordinary share in 2021.

Statement of Comprehensive Income

 

 

Year ended 31 October 2022

Year ended 31 October 2021

Note

 

Revenue £'000

Capital £'000

Total £'000

 

Revenue £'000

Capital £'000

Total £'000

(Losses)/gains on investments at fair value through profit or loss

4

-

(143,283)

(143,283)

-

64,051

64,051

Transaction costs

8

-

832

832

-

387

387

Losses on currency movements

-

(354)

(354)

-

-

-

Net investment (losses)/gains

 

-

 

(142,805)

 

(142,805)

 

-

 

64,438

 

64,438

Investment income

5

4,108

-

4,108

3,667

-

3,667

Investment management fees

6

(1,020)

-

(1,020)

(2,753)

-

(2,753)

Other expenses

6

(913)

-

(913)

(882)

-

(882)

Operating (loss)/profit before finance costs and taxation

 

2,175

 

(142,805)

 

(140,630)

 

32

 

64,438

 

64,470

Finance costs

9

(109)

-

(109)

(176)

-

(176)

Operating (loss)/profit before taxation

 

2,066

 

(142,805)

 

(140,739)

 

(144)

 

64,438

 

64,294

Withholding tax expense

(215)

-

(215)

(138)

-

(138)

Total (loss)/profit and comprehensive income for the year

 

1,851

 

(142,805)

 

(140,954)

 

(282)

 

64,438

 

64,156

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings and diluted earnings per Ordinary share

10

 

4.00p

 

(308.70p)

 

(304.70p)

 

(0.61p)

 

140.19p

 

139.58p

The Total column of this statement represents the Company's Statement of Comprehensive Income, prepared under IFRS. The revenue and capital columns, including the revenue and capital earnings per Ordinary share data, are supplementary information prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued during the year.

The notes form part of these financial statements.

 

Statement of Financial Position

 

 

Note

As at 31 October 2022 £'000

As at 31 October 2021 £'000

Non-current assets

Investments at fair value through profit or loss

4

224,064

112,905

Current assets

Cash and bank

8,534

201,795

Sales for future settlement

-

59,838

Other receivables

56

119

 

8,590

 

261,752

Total assets

 

232,654

 

374,657

Current liabilities

Purchases for future settlement

(222)

-

Other payables

(564)

(835)

Finance costs payable

9

(25)

(34)

Total liabilities

 

(811)

 

(869)

Net assets

 

231,843

 

373,788

Equity

Share capital

12

147,744

148,735

Capital reserve

13

87,739

230,544

Revenue reserve

(3,640)

(5,491)

Total equity

 

231,843

 

373,788

Net assets per Ordinary share

14

 

511.98p

 

813.20p

Approved by the Board of Directors and authorised for issue on 13 February 2023 and signed on its behalf by:

Helen Green

Director

Mark Bridgeman

Director

The notes form part of these financial statements.

Incorporated in Guernsey: Company registration number 50900

 

Statement of Changes in Equity

 

 

For the year ended 31 October 2022

Note

Share capital £'000

Capital reserve £'000

Revenue reserve £'000

Total £'000

Balance at 1 November 2021

 

148,735

 

230,544

 

(5,491)

 

373,788

Loss for the year

-

(142,805)

1,851

(140,954)

Scheme of reconstruction:

Ordinary shares issued

62,037

-

-

62,037

Ordinary shares repurchased

(55,291)

-

-

(55,291)

Tender offer and share issue costs

12

(177)

-

-

(177)

Share buybacks

12

(7,560)

-

-

(7,560)

Balance at 31 October 2022

 

147,744

 

87,739

 

(3,640)

 

231,843

 

For the year ended 31 October 2021

 

Note

 

Share capital £'000

 

Capital reserve £'000

 

Revenue reserve £'000

 

Total £'000

Balance at 1 November 2020

 

149,616

 

176,563

 

(5,209)

 

320,970

Profit for the year

-

64,438

(282)

64,156

Dividends paid

11

-

(10,457)

-

(10,457)

Tender offer and share issue costs(Scheme of Reconstruction)

12

(881)

-

-

(881)

Balance at 31 October 2021

 

148,735

 

230,544

 

(5,491)

 

373,788

The capital reserve at 31 October 2022 is split between realised gains of £207,445,000 and unrealised losses of £119,706,000 (2021: realised gains of £183,241,000 and unrealised gains of £47,303,000).

The revenue reserve and realised element of the capital reserve represents the amount of the Company's retained reserves.

The notes form part of these financial statements.

 

Statement of Cash Flows

 

 

Note

Year ended 31 October 2022 £'000

Year ended 31 October 2021 £'000

Operating activities

Cash inflow from investment income

4,187

3,885

Cash outflow from management expenses

(2,009)

(4,093)

Cash inflow from disposal of investments1

311,504

401,220

Cash outflow from purchase of investments1

(446,496)

(183,626)

Cash outflow from withholding tax

(215)

(138)

Net cash flow (used in)/from operating activities

 

15

 

(133,029)

 

217,248

Financing activities

Repayment of bank borrowings

9

-

(25,000)

Proceeds from bank borrowings

9

-

12,500

Borrowing commitment fee and interest charges

9

(118)

(142)

Dividends paid

11

-

(10,457)

Scheme of reconstruction2

Ordinary shares issued

3,257

-

Ordinary shares repurchased

(55,291)

-

Tender offer and share issue costs paid

(388)

(669)

Share buybacks

20

(7,338)

-

Net cash flow used in financing activities

 

(59,878)

 

(23,768)

Net (decrease) / increase in cash and cash equivalents

 

(192,907)

 

193,480

Effect of foreign exchange

(354)

-

Cash and cash equivalents at start of the year

201,795

 

8,315

Cash and cash equivalents at end of the year

 

8,534

 

201,795

1 Cash flows from the disposal and purchase of investments have been classified as components of cash flow from operating activities because they form part of the Company's operating activities.

2 Actual proceeds received as a result of the Scheme of reconstruction on 9 November 2021 amounted to £3,257,000 with the remainder being received in the form of a UK treasury bill amounting to £57,980,000. The UK treasury bill was immediately sold on 10 November 2021 and subsequently deployed into Chinese equities.

The notes form part of these financial statements.

 

 

Notes to the Financial Statements

 

For the Year Ended 31 October 2022

1. Reporting entity

abrdn China Investment Company Limited (the "Company") is a closed-ended investment company, registered in Guernsey on 16 September 2009. The Company's registered office is 11 New Street, St Peter Port, Guernsey, GY1 2PF. The Company's Ordinary shares have a premium listing on the London Stock Exchange and commenced trading on 10 November 2009. The Company changed its name to abrdn China Investment Company Limited on 26 October 2021 (formerly Aberdeen Emerging Markets Investment Company Limited). The financial statements of the Company are presented for the year ended 31 October 2022.

The Company invests in companies listed, incorporated or domiciled in the People's Republic of China ("China"), or companies that derive a significant proportion of their revenues or profits from China operations or have a significant proportion of their assets there. Prior to the combination with Aberdeen New Thai Investment Trust PLC on 26 October 2021, the Company was managed in accordance with its previous investment objective, which was to achieve consistent returns for shareholders in excess of the MSCI Emerging Markets Net Total Return Index in sterling terms. In furtherance of the new investment policy, the portfolio will normally consist principally of quoted equity securities and depositary receipts although unlisted companies, fixed interest holdings or other non-equity investments may be held. Investments in unquoted companies will be made where the Manager has a reasonable expectation that the company will seek a listing in the near future. The portfolio is actively managed and may be invested in companies of any size and in any sector.

Manager

The investment activities of the Company were managed by abrdn Fund Managers Limited ("AFML") during the year ended 31 October 2022.

Non-mainstream pooled investments ("NMPIs")

The Company currently conducts its affairs so that the shares issued by the Company can be recommended by Independent Financial Advisers to ordinary retail investors in accordance with the Financial Conduct Authority's rules in relation to NMPIs and intends to continue to do so for the foreseeable future.

2. Basis of preparation

(a) Statement of compliance

The financial statements, which give a true and fair view, have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the IASB and are in compliance with the Companies (Guernsey) Law, 2008. There were no significant changes in the accounting policies of the Company in the year to 31 October 2022.

Where presentational guidance set out in the Statement of Recommended Practice ("SORP") for Investment Companies issued by the Association of Investment Companies ("AIC") in July 2022 is consistent with the requirements of IFRS, the Directors have prepared the financial statements on a basis compliant with the recommendations of the SORP.

The "Total" column of the Statement of Comprehensive Income is the profit or loss account of the Company. The "Capital" and "Revenue" columns provide supplementary information prepared under guidance published by the AIC.

The financial statements were approved and authorised for issue by the Board on 13 February 2023.

This report will be sent to shareholders and copies will be made available to the public at the Company's registered office. It will also be made available on the Company's website: abrdnchina.co.uk.

(b) Going concern

The Directors have adopted the going concern basis in preparing the financial statements. The Board formally considered the Company's going concern status at the time of the publication of these financial statements and a summary of the assessment is provided below.

Since the adoption of the new investment policy, as approved by shareholders at the EGM held on 26 October 2021, the Board considered it appropriate to reset the five year interval between Continuation Resolutions so that the next Continuation Resolution will be put to shareholders at the Annual General Meeting of the Company to be held in 2027.

The Directors believe that the Company has adequate resources to continue in operational existence for at least 12 months from the date of approval of this document. In reaching this conclusion, the Directors have considered the liquidity of the Company's portfolio of investments as well as its cash position, income and expense flows.

As at 31 October 2022, the Company held £8.5 million in cash and £224.1 million in investments. It is estimated that approximately 99% of the investments held at the year end could be realised in one month. The total operating expenses for the year ended were £1.9 million, which on an annualised basis represented approximately 0.60% of average net assets during the year. The Company also incurred £0.1 million of finance costs. At the date of approval of this report, based on the aggregate of investments and cash held, the Company has substantial operating expenses cover. The Company's net assets at 9 February 2023 were £311.0 million.

The Company has a £15 million revolving loan facility with Industrial and Commercial Bank of China limited, London Branch ('ICBC'), terminating in April 2024. As at 31 October 2022, none of the ICBC facility was drawn down. The liquidity of the Company's portfolio, as mentioned above, sufficiently supports the Company's ability to repay its borrowings at short notice. Since the Financial Year ended the Investment Manager has drawn down a total of CNH 106m (£12.7m) in two tranches.

In light of the Covid-19 pandemic, the Directors have fully considered and assessed the Company's portfolio of investments. A prolonged and deep market decline could lead to falling values of the investments or interruptions to cashflow. However, the Company currently has more than sufficient liquidity available to meet any future obligations.

The Directors are satisfied that it is appropriate to adopt the going concern basis in preparing the financial statements and, after due consideration, that the Company is able to continue in operation for a period of at least 12 months from the date of approval of these financial statements.

(c) Basis of measurement

The financial statements have been prepared on the historical cost basis except for investments held at fair value through profit or loss which are measured at fair value.

(d) Functional and presentation currency

The Company's investments are largely exposed to Chinese markets. However, the Company's Ordinary shares are issued in GBP sterling and the majority of its investors are UK based. The vast majority of service providers are also denominated in sterling. Therefore, the financial statements are presented in sterling, which is the Company's functional currency. All financial information presented in sterling has been rounded to the nearest thousand pounds.

(e) Capital reserve

Profits achieved by selling investments and changes in fair value arising upon the revaluation of investments that remain in the portfolio are all charged to profit or loss in the capital column of the Statement of Comprehensive Income and allocated to the capital reserve. The capital reserve attributable to realised profits is also used to fund dividend distributions.

(f) Revenue reserve

The balance of all items allocated to the revenue column of the Statement of Comprehensive Income in each year is transferred to the Company's revenue reserve. The revenue reserve is also used to fund dividend distributions.

(g) Use of estimates, assumptions and judgements

The preparation of the financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.

Use of estimates and assumptions

Estimates and underlying assumptions are reviewed on an on-going basis. Revisions to accounting estimates are recognised in the period in which the estimates are revised and in future periods affected.

Information about significant areas of estimation uncertainty and critical judgements in applying accounting policies that have the most significant effect on the amounts recognised in the financial statements are described below.

Classification and valuation of investments

Investments are designated as fair value through profit or loss on initial recognition and are subsequently measured at fair value. The valuation of such investments requires estimates and assumptions made by the management of the Company depending on the nature of the investments as described in notes 3 (a) and 18 and fair value may not represent actual realisable value for those investments.

Allocation of investments to fair value hierarchy

IFRS requires the Company to measure fair value using the following fair value hierarchy that reflects the significance of the inputs used in making the measurements. IFRS establishes a fair value hierarchy that prioritises the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of fair value hierarchy under IFRS are as follows:

Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2 - inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices); and

Level 3 - inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs).

The level in the fair value hierarchy within which the fair value measurement is categorised in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgement, considering factors specific to the asset or liability.

Use of judgements

The determination of what constitutes 'observable' requires significant judgement by the Company. The Company considers observable data to be that market data that is readily available, regularly distributed or updated, reliable and verifiable, not proprietary and provided by independent sources that are actively involved in the relevant market.

3. Significant accounting policies (a) Investments

(a) Investments

As the Company's business is investing in financial assets with a view to profiting from their total return in the form of increases in fair value, financial assets are designated as fair value through profit or loss on initial recognition. These investments are recognised on the trade date of their acquisition at which the Company becomes a party to the contractual provisions of the instrument. At this time, the best evidence of the fair value of the financial assets is the transaction price. Transaction costs that are directly attributable to the acquisition or issue of the financial assets are charged to profit or loss in the Statement of Comprehensive Income as a capital item. Subsequent to initial recognition, investments designated as fair value through profit or loss are measured at fair value with changes in their fair value recognised in profit or loss in the Statement of Comprehensive Income and determined by reference to:

i) investments quoted or dealt on recognised stock exchanges in an active market are valued by reference to their market bid prices;

ii) investments other than those in i) above which are dealt on a trading facility in an active market are valued by reference to broker bid price quotations, if available, for those investments;

iii) investments in underlying funds, which are not quoted or dealt on a recognised stock exchange or other trading facility or in an active market, are valued at the net asset values provided by such entities or their administrators. These values may be unaudited or may themselves be estimates and may not be produced in a timely manner. If such

information is not provided, or is insufficiently timely, the Investment Manager uses appropriate valuation techniques to estimate the value of investments. In determining fair value of such investments, the Investment Manager takes into consideration the relevant issues, which may include the impact of suspension, redemptions, liquidation proceedings and other significant factors. Any such valuations are assessed and approved by the Directors. The estimates may differ from actual realisable values;

iv) investments which are in liquidation are valued at the estimate of their remaining realisable value; and

v) any other investments are valued at the directors' best estimate of fair value.

Transfers between levels of the fair value hierarchy are recognised as at the end of the reporting period during which the change has occurred.

Investments are derecognised on the trade date of their disposal, which is the point where the Company transfers substantially all the risks and rewards of the ownership of the financial asset. Gains or losses are recognised in profit or loss in the capital column of the Statement of Comprehensive Income. The Company uses the weighted average cost method to determine realised gains and losses on disposal of investments.

(b) Foreign currency

Transactions in foreign currencies are translated into sterling at the exchange rate at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the reporting date are retranslated into sterling at the spot exchange rate at that date. Non-monetary assets and liabilities denominated in foreign currencies that are measured at fair value through profit or loss are retranslated into sterling at the exchange rate at the date that the fair value was determined. Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated into sterling using the exchange rate at the date of the transaction.

Foreign currency differences arising on retranslation are recognised in profit or loss and, depending on the nature of the gain or loss, are allocated to the revenue or capital column of the Statement of Comprehensive Income. Foreign currency differences on retranslation of financial instruments designated as fair value through profit or loss are shown in the "Losses on currency movements" line.

(c) Income from investments

Dividend income is recognised when the right to receive it is established and is reflected in the Statement of Comprehensive Income as Investment income in the revenue column. For quoted equity securities this is usually on the basis of ex-dividend dates. For unquoted investments this is usually on the entitlement date confirmed by the relevant holding. Income from bonds is accounted for using the effective interest rate method.

Special dividends and distributions described as capital distributions are assessed on their individual merits and may be credited to the capital reserve if considered to be closely linked to reconstructions of the investee company or other capital transactions. Bank interest receivable is accounted for on a time apportionment basis and is based on the prevailing variable interest rates for the Company's bank accounts.

(d) Treasury shares

Where the Company purchases its own share capital, the consideration paid, which includes any directly attributable costs, is recognised as a deduction from equity shareholders' funds through the Company's reserves. When such shares are subsequently sold or re-issued to the market any consideration received, net of any directly attributable incremental transaction costs, is recognised as an increase in equity shareholders' funds through the share capital account. Shares held in treasury are excluded from calculations when determining NAV per share.

(e) Cash and cash equivalents

Cash comprises cash and demand deposits. Cash equivalents, which include bank overdrafts, are short term, highly liquid investments that are readily convertible to known amounts of cash, are subject to insignificant risks of changes in value, and are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.

(f) Investment management fees and finance costs

Investment management fees and finance costs are charged to the Statement of Comprehensive Income as a revenue item and are accrued monthly in arrears. Finance costs include interest payable and direct loan costs. Performance-related fees, if any, are payable directly by reference to the capital performance of the Company and are therefore charged to profit or loss in the Statement of Comprehensive Income as a capital item.

(g) Financial liabilities

Financial liabilities (including bank loans) are classified according to the substance of the contractual arrangements entered into. Financial liabilities held at fair value through profit or loss are measured initially at fair value, with transaction costs recognised in profit or loss in the Statement of Comprehensive Income.

(h) Taxation

Investment trusts which have approval under Section 1158 of the Corporation Tax Act 2010 are not liable for taxation on capital gains. The Company has successfully applied and has been granted approval as an Investment Trust by HMRC.

Dividend and interest income received by the Company may be subject to withholding tax imposed in the country of origin. The tax charges shown in profit or loss in the Statement of Comprehensive Income relate to overseas withholding tax on dividend income.

Deferred taxation is recognised in respect of all timing differences that have originated but not reversed at the financial reporting date, where transactions or events that result in an obligation to pay more tax in the future or right to pay less tax in the future have occurred at the financial reporting date. This is subject to deferred tax assets only being recognised if it is considered more likely than not that there will be suitable profits from which the future reversal of the timing differences can be deducted. Deferred tax assets and liabilities are measured at the rates applicable to the legal jurisdictions in which they arise.

(i) Operating segments

IFRS 8, 'Operating segments' requires a 'management approach', under which segment information is presented on the same basis as that used for internal reporting purposes. The Board, as a whole, has been determined as constituting the chief operating decision maker of the Company. The Board has considered the requirements of the standard and is of the view that the Company is engaged in a single segment of business, which is investing in a portfolio of companies which give exposure to the Chinese market. The key measure of performance used by the Board is the NAV of the Company (which is calculated under IFRS). Therefore, no reconciliation is required between the measure of profit or loss used by the Board and that contained in the financial statements.

Further information on the Company's operating segment is provided in note 19.

(j) Offsetting

Financial assets and liabilities are offset and the net amount presented in the Statement of Financial Position when, and only when, the Company has a legal right to set off the recognised amounts and it intends to either settle on a net basis or to realise the asset and settle the liability simultaneously.

Income and expenses are only presented on a net basis when permitted under IFRS.

(k) Structured entities

A structured entity is an entity that has been designed so that voting or similar rights are not the dominant factor in deciding who controls the entity, such as when any voting rights relate to administrative tasks only and the relevant activities are directed by means of contractual arrangements. A structured entity often has some or all of the following features or attributes; (a) restricted activities, (b) a narrow and well-defined objective, such as to provide investment opportunities for investors by passing on risks and rewards associated with the assets of the structured entity to investors, (c) insufficient equity to permit the structured entity to finance its activities without subordinated financial support and (d) financing in the form of multiple contractually linked instruments to investors that create concentrations of credit or other risks.

The Company holds shares, units or partnership interests in the funds or investment products presented in the Company's portfolio. The Company does not consider its investments in listed funds to be structured entities but does consider its investments in unlisted funds to be investments in structured entities because the voting rights in such entities are limited to administrative tasks and are not the dominant factor in deciding who controls those entities.

Changes in fair value of investments, including structured entities, are included in profit or loss in the Statement of Comprehensive Income.

(l) Dividend payable

Final dividends payable to equity shareholders are recognised in the financial statements when they have been approved by shareholders and become a liability of the Company. Interim dividends payable are recognised in the period in which they are paid. The capital and revenue reserve may be used to fund dividend distributions.

(m)  New standards, interpretations and/or amendments relevant to the Company

Effective in the current financial year

A number of new standards, amendments to standards are effective for the annual periods beginning after 1 January 2021.

None of these are expected to have a significant effect on the measurement of the amounts recognised in the financial statements of the Company. The Company intends to adopt the standards and interpretations in the reporting period when they become effective and the Board does not anticipate that the adoption of these standards and interpretations in future periods will materially impact the Company's financial results in the period of initial application although there may be revised presentations to the financial statements and additional disclosures.

Interest Rate Benchmark Reform-Phase 2

Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16. - The Phase 2 amendments address issues that might affect financial reporting during the reform of an interest rate benchmark, including the effects of changes to contractual cash flows or hedging relationships arising from the replacement of an interest rate benchmark with an alternative benchmark rate

Not yet in effect

There are a number of new standards, interpretations, and/or amendments, which did not become effective during the financial year under review.

At the date of approval of these financial statements, the following standards and interpretations were amended during the year:

IAS 1 and IFRS 2 - Disclosure of Accounting policies (effective 1 January 2023).

IAS 8 - Definition of Accounting Estimates (effective 1 January 2023).

The Board have assessed new but not yet effective standards applicable to the Company and have concluded that they will not have a material impact to the Company.

 

4. Investments at fair value through profit or loss and classification of financial instruments

 

2022 £'000

2021 £'000

 

 

Quoted and listed closed end fund investments

222,745

39,890

 

 

Open ended fund and limited liability partnership investments

1,319

73,015

 

 

Total fair value investments at 31 October

224,064

 

112,905

 

 

Investments held at fair value through profit or loss

 

 

Opening book cost

65,600

234,136

 

 

Opening investment holding gains

47,305

90,839

 

 

Opening fair value

112,905

 

324,975

 

 

Analysis of transactions made during the year

 

 

Purchases at cost

446,496

183,626

 

 

Sales proceeds received

(193,446)

(460,134)

 

 

Gains on investments

25,119

107,972

 

Movement in investment holding losses

(167,010)

(43,534)

 

Closing fair value

 

224,064

 

112,905

 

Closing book cost

343,770

65,600

 

Closing investment holding (losses)/gains

(119,706)

47,305

 

Closing fair value

 

224,064

 

112,905

The company received £193,446,000 (2021: £460,134,000) from investments sold during the year. The book cost of these investments when they were purchased was £168,888,000 (2021: £352,162,000). These investments have been revalued over time and until they were sold any unrealised gains/losses were included in the fair value of the investments.

The table below sets out the classifications of the carrying amounts of the Company's financial assets and financial liabilities into categories of financial instruments.

Financial instruments as at 31 October 2022

Financial assets measured at fair value £'000

Financial assets measured at amortised cost £'000

Financial liabilities measured at fair value £'000

Financial liabilities measured at amortised cost £'000

Total £'000

Investments at fair value through profit or loss

224,064

-

-

-

224,064

Cash and cash equivalents

-

8,534

-

-

8,534

Sales for future settlement and other receivables

-

56

-

-

56

Purchases for future settlement and other payables

-

-

(811)

-

(811)

Total

 

224,064

 

8,590

 

(811)

 

-

 

231,843

Financial instruments as at 31 October 2021

 

Financial assets measured at fair value £'000

Financial assets measured at amortised cost £'000

Financial liabilities measured at fair value £'000

Financial liabilities measured at amortised cost £'000

Total £'000

 

 

Investments at fair value through profit or loss

112,905

-

-

-

112,905

 

 

Cash and cash equivalents

-

201,795

-

-

201,795

 

 

Sales for future settlement and other receivables

-

59,957

-

-

59,957

 

 

Purchases for future settlement and other payables

-

-

(869)

-

(869)

 

 

Total

 

112,905

 

261,752

 

(869)

 

-

 

373,788

 

5. Investment income

2022 £'000

2021 £'000

Dividends from UK Investments

-

2,824

Dividends from Overseas Investments

4,065

843

Other income

43

-

Total Investment income

4,108

3,667

6. Investment Management fee and other expenses

 

2022 £'000

2021 £'000

 

 

Management fee

 

1,020

2,753

 

 

Administration fees

203

202

 

 

Depositary and custody service fees

211

172

 

 

Registration fees

31

34

 

 

Directors' fees

179

140

 

 

Auditor's fees:

 

 

Audit services

51

47

 

 

Non-audit services

17

17

 

 

Promotional fees

-

123

 

 

Broker fees

76

51

 

 

Miscellaneous expenses

145

96

 

 

Total other expenses

 

913

882

 

 

Total Investment Management fee and other expenses

 

1,933

3,635

 

Management fee (during the year ended 31 October 2021 and up to 9 November 2021)

Management services are provided by abrdn Fund Managers Limited ("AFML"). During the year, the management fee was payable monthly in arrears (and pro rata for part of any month during which the management agreement is in force) at an annualised rate of 0.80% of net assets, reduced by the proportion of the Company's net assets invested in funds which are managed by the abrdn Group ("abrdn Funds"), other than the investments in Aberdeen Standard SICAV I -China A Share Equity Fund and Aberdeen Standard SICAV I - Frontier Markets Bond Fund, which are held in share classes not subject to management charges at a fund level and the Manager was therefore entitled to a fee on the value of those investments.

Management fee and Agreement (following the Completion of the Scheme of Reconstruction on 9 November 2021) (the "Scheme")

Following completion of the Scheme, the Company entered into a new management agreement (the "Management Agreement") with abrdn Fund Managers Limited ("AFML"), pursuant to which the management fee payable by the Company to AFML is calculated by reference to the market capitalisation of the Company, rather than its net assets (as was the case). The new management fee is structured on a tiered basis, with the first £150 million of market capitalisation being charged at 0.80%, the next £150 million being charged at 0.75%, and amounts thereafter being charged at 0.65%.

AFML has agreed to make a contribution to the costs of implementing the Scheme by means of a waiver of the management fee for the first six months following the completion of the Scheme.

The Management Agreement is terminable by either party on not less than six months' written notice at any time.

Promotional fee

During the year the Company paid fees of £nil (2021: 123,400) to AFML for the provision of promotional activities.

Company Secretary and Administrator fees

Vistra Fund Services (Guernsey) Limited ("Vistra") is appointed as Administrator and Secretary to the Company. Vistra is appointed under a contract subject to ninety days' written notice and receives a fee at a rate of £40,000 per annum plus certain additional fees (during the year ended 31 October 2022, Vistra's fee for ad hoc meetings held amounted to £8,250 (2021: £8,250)). Vistra also receives the fees payable to the UK Administration Agent.

UK Administration agent fees

Sanne Fund Services (UK) Limited (formerly PraxisIFM Fund Services (UK) Limited) is appointed by Vistra to act as administration agent in the United Kingdom. Sanne is appointed under a contract subject to not less than ninety days' notice. The UK Administration Agent receives from the Administrator a monthly fee equal to one twelfth of 0.1% of NAV subject to a maximum fee for the year ended 31 October 2022 of £163,022 (2021: £153,774) per annum. The maximum fee is increased annually, in November, by the change in the UK Retail Price Index (all items) over the preceding 12 months.

Depositary and custody services and fees

Northern Trust (Guernsey) Limited, receives fees for Depositary services calculated at the rate of 2.95 basis points per annum subject to a minimum annual fee of £20,000, effective 1 August 2018. Northern Trust (Guernsey) Limited also receives a fee for custody services. It receives an asset based fee equal to between 1.00 basis points and 60.00 basis points of the value of the assets of the Company. Transaction based fees are also payable of between £10 and £140 per transaction. The variable fees are dependent on the countries in which the individual holdings are registered. The fees for depositary and custody services payable for the year were £211,000 (2021: £172,000).

7. Directors' fees

The Director's fees payable for the year were £179,000 (2021: £140,200). There were no other emoluments paid to the Directors.

8. Transaction charges

2022 £'000

2021 £'000

Transaction costs on purchases of investments

620

137

Transaction costs on sales of investments

212

250

Total transaction costs included in gains on investments

832

 

387

9. Bank loan payable and finance costs

In April 2022, the Company entered into an unsecured multicurrency revolving loan facility with ICBC. The facility will be utilised for general working capital purposes and for the acquisition of investments in accordance with the Company's investment policy.

Under the terms of the facility, the Company also has the option to increase the level of the commitment from £15 million to £30 million at any time, subject to the Lender's credit approval. There was no drawdown as at the year end. On 15 December 2022, the Company utilised CNH 40,000,000 (£4.67 million) of its unsecured multicurrency revolving loan facility.

Bank loan

2022 £'000

2021 £'000

Opening balance

 

-

 

12,500

Proceeds from bank borrowings (drawdowns)

-

12,500

Repayment of bank borrowings (repayments)

-

(25,000)

Closing balance

 

-

 

-

Finance costs

 

2022 £'000

 

2021 £'000

Interest payable

70

151

Facility arrangement fees and other charges

39

25

Total finance costs

 

109

 

176

At 31 October 2022, Finance costs payable of £nil (2021: £34,000) was accrued in the Statement of Financial Position.

10. Basic earnings and diluted earnings per Ordinary share

Basic earnings and diluted earnings per Ordinary share is based on the total comprehensive income for the year ended 31 October 2022, being a loss of £140,954,000 (2021: profit of £64,156,000) attributable to the weighted average of 46,260,167 (2021: 45,965,159) Ordinary shares in issue (excluding shares held in treasury) during the period ended 31 October 2022.

Supplementary information is provided as follows: revenue per share is based on the net revenue profit of £1,851,000 (2021: revenue loss of £282,000) and capital earnings per share is based on the net capital loss of £142,805,000 (2021: profit of £64,438,000) attributable to the above Ordinary shares.

11. Dividends paid

There were no dividends paid or declared during the year ended 31 October 2022. The Board declares an interim dividend in respect of the year ended 31 October 2022 of 3.2p per Ordinary share which will be payable to Shareholders on 17 March 2023, with a record date of 24 February 2023 and ex-dividend date of 23 February 2023.

Dividends paid during the year ended 31 October 2021

Dividend type (in respect of the year) - Pay date

Pence per Ordinary share

£'000

Fourth interim (2020) - paid 18 December 2020

5.50

2,528

First interim (2021) - paid 26 March 2021

5.75

2,643

Second interim (2021) - paid 25 June 2021

5.75

2,643

Third interim (2021) - paid 24 September 2021

5.75

2,643

Total dividends

 

22.75

 

10,457

12. Share capital

For the year ended 31 October 2022

Authorised

Ordinary shares of 1 p nominal value £'000

Allotted, issued and fully paid

Ordinary shares with voting rights (excluding treasury shares)

Treasury shares

Opening number of shares

Unlimited

546

54,618,507

45,965,159

8,653,348

Scheme of reconstruction

Ordinary shares issued

76

7,554,440

7,554,440

-

Ordinary shares repurchased

-

-

(6,894,773)

6,894,773

Purchase of own shares

-

-

(1,341,251)

1,341,251

Closing number of shares

 

Unlimited

 

622

 

62,172,947

 

45,283,575

 

16,889,372

 

 

 

 

 

 

 

 

 

 

 

For the year ended 31 October 2021

 

Authorised

 

Ordinary shares of 1 p nominal value £'000

 

Allotted, issued and fully paid

 

Ordinary shares with voting rights (excluding treasury shares)

 

Treasury shares

Opening number of shares

Unlimited

546

54,618,507

45,965,159

8,653,348

Purchase of own shares

-

-

-

-

Closing number of shares

 

Unlimited

 

546

 

54,618,507

 

45,965,159

 

8,653,348

Scheme of Reconstruction

On 9 November 2021 the Company completed and announced its Scheme of Reconstruction (the "Scheme"). As a result of the Scheme, the change in share capital of the Company was as follows:

Share issue - The Company acquired approximately £62 million of net assets from New Thai in consideration for the issue of 7,554,440 new Ordinary shares in the Company.

Tender Offer - A total of 6,894,773 Ordinary shares were repurchased by the Company on 10 November 2021 under the Tender Offer and held in treasury at an aggregate cost to the Company of £55 million.

The cost of implementing the Scheme paid during the year was £177,000 (2021: £881,000).

Purchases of own shares

There were 1,341,251 Ordinary shares purchased during the year (2021: none)).

Share capital account

The aggregate balance (including share premium) standing to the credit of the share capital account as at 31 October 2022 was £147,444,000 (2021: £148,735,000).

Ordinary shares

Voting rights (as at 31 October 2022)

Holders of Ordinary shares are entitled to attend, speak and vote at general meetings of the Company. Each Ordinary share (excluding shares in treasury) carries one vote. Treasury shares do not carry voting rights.

At its financial year end, the Company had 386 registered shareholders. At 31 October 2022, the Company was notified of 3 shareholders who each held more than 10% of the issued share capital and their holdings were 27.8% (2021: 28.7%), 23.5% (2021: 22.1%) and 19.5% (2021: 21.8%) respectively.

Dividends

The holders of Ordinary shares are entitled to such dividend as may be declared by the Company from time to time. Shares held in treasury do not receive dividends.

Capital entitlement

On a winding up, the Ordinary shares (excluding treasury shares) shall rank pari passu for the nominal capital paid up thereon and in respect of any surplus. Shares held in treasury have no capital entitlement on a winding up of the Company.

13. Capital reserve

2022 £'000

2021 £'000

Realised gains on investments and other capital reserve movements

Opening balance

183,241

85,726

Dividends paid from capital reserves

-

(10,457)

Gains from disposal of investments*

45,085

114,954

Losses from disposal of investments*

(20,527)

(6,982)

Foreign exchange losses

(354)

-

Balance at 31 October

 

207,445

 

183,241

Investments held

Opening balance

47,303

90,837

Movement in unrealised gain on revaluation of investments held*

1,454

27,661

Movement in unrealised loss on revaluation of investments held*

(168,463)

(71,195)

Balance at 31 October

 

(119,706)

 

47,303

Capital reserve balance at 31 October

 

87,739

 

230,544

* Net gains on investments held at fair value through profit or loss figure for the year ended 31 October 2022 totalled £141,891,000 (2021: £64,438,000).

14. Net asset value ("NAV") per Ordinary share

The NAV per Ordinary share is based on net assets of £231,843,000 (2021: £373,788,000) divided by 45,283,575 (2021: 45,965,159) Ordinary shares in issue (excluding shares held in treasury) at the year end.

The table below is a reconciliation between the NAV per Ordinary share as announced on the London Stock Exchange and the NAV per Ordinary share disclosed in these financial statements.

 

 

 

 

 

 

As at 31 October 2022

As at 31 October 2021

 

 

Net assets (£'millions)

 

NAV per Ordinary share (p)

 

Net assets (£'millions)

 

NAV per Ordinary share (p)

 

NAV as published on 1 November 2022 and 1 November 2021 respectively

231.8

511.98

373.7

813.09

 

Revaluation adjustments - delayed prices

-

-

0.1

0.11

 

NAV as disclosed in these financial statements

 

231.8

 

511.98

 

373.8

 

813.20

 

15. Reconciliation of operating profit to net cash flow from operating activities

2022 £'000

2021 £'000

Operating profit before finance costs and taxation

(140,630)

64,470

Less: Tax deducted at source on income from investments

(215)

(138)

Add: Realisation of investments at book cost

168,327

352,162

Less: Purchase of investments

(446,496)

(183,626)

Less: Adjustment for unrealised losses / (gains)

167,011

43,534

Less: Adjustment for accrued (Scheme of reconstruction)

-

(212)

Effect of foreign exchange

354

-

Increase in trade receivables

59,889

(58,666)

(Decrease)/increase in trade payables

(49)

(276)

Net cash flow from operating activities

 

(191,809)

 

217,248

16. Related party disclosures

Manager

Management fees payable are shown in the Statement of Comprehensive Income and note 6. As at 31 October 2022, management fees of £291,000 (2021: £472,000) were accrued in the Statement of Financial Position. Total management fees for the year were £1,020,000 (2021: £2,753,000).

Details of promotional fees payable can be found in note 6. The balance outstanding at the financial year end was £nil (2021: £41,000).

Investments held by the Company which are managed by the abrdn plc Group

As at 31 October 2022, the Company held the following investments managed by the abrdn Group;

As at 31 October 2022 £'000

As at 31 October 2021 £'000

Aberdeen Standard SICAV I - China A Share Equity Fund

-

21,874

abrdn New India Investment Trust PLC

-

10,826

abrdn Asian Income Fund Limited

-

6,215

Aberdeen Standard SICAV I - Frontier Markets Bond Fund

-

-

Asia Dragon Trust PLC

-

-

Total

 

-

 

38,915

Directors

Total fees for the Directors in the year ended 31 October 2022 were £179,000 (2021: £140,200). There were no outstanding fees due to the Directors at the year end (2021: £nil). Details of Directors' share holdings in the Company can be found in the Annual Report for the Financial Year ended 31 October 2022.

17. Financial instruments - risk profile

Risk Management Framework

The Company has established procedures to enable it to manage its financial risks. The main financial risks faced from its financial instruments are market risk, liquidity risk and credit risk, which are discussed as follows.

Market risk

i) Risks associated with Chinese and emerging markets

Investment in certain emerging securities markets, including China, may involve a greater degree of risk than that associated with investment in more developed securities markets. In particular, in certain countries in which the Company is proposing to invest:

liquidity and settlement risks may be greater;

accounting standards may not provide the same degree of shareholder protection as would generally apply internationally;

• national policies may restrict the investment opportunities available to foreign investors, including restrictions on investing in issuers or industries deemed sensitive to relevant national interests; ·

the fiscal and monetary systems remain relatively undeveloped and this may affect the stability of the economic and financial markets of those countries;

substantial limitations may exist with respect to the Company's ability to repatriate investment income, capital or the proceeds of sales of securities by foreign investors; and

assets may be subject to increased political and/or regulatory risk.

The day to day management of the market risks is the responsibility of the Investment Manager, which analyses markets within a framework of quality, value, growth and change. The Board believes the Investment Manager utilises its proven research and management selection experience to ensure that these risks are minimised, as far as is possible. The investment policy employed by the Investment Manager ensures that diversification within investee funds is taken into account when deciding on the size of each investment so the Company's exposure to any one underlying company should never be excessive. The Company's market positions are monitored by the Board in the monthly portfolio valuations and at Board meetings.

ii) Currency risk

As stated under i) above, the Company invests in Chinese markets. It is therefore exposed to currency risks which affect both the performance of its investee funds and also the value of the Company's holdings against the Company's functional currency, sterling. The Company holds sterling and occasionally other foreign currencies for brief periods in its account with the custodian, but only at times when it expects to invest that currency into portfolio holdings shortly after.

It is not the Company's policy to hedge against foreign currency movements, nor does the Company use financial instruments to mitigate the currency exposure in the period between the time that income is included in the financial statements and its receipt. Movements in exchange rates are likely to affect directly and indirectly the value of the Company's investments.

Currency price risk sensitivity

The effect of a 1% appreciation/depreciation in the exchange rate of the Chinese Yuan over sterling would have resulted in an increase/decrease of £156,000 (2021: £nil) in the Company's investments held at fair value through profit or loss at the Statement of Financial Position date. This analysis assumes that all other variables remain constant.

iii) Interest rate risk

No significant interest rate risks arise in respect of any current asset. The Company, generally, does not hold significant cash balances, with short-term borrowings being used when required. All cash held as a current asset is sterling or US dollar.

In April 2022, the Company entered into an unsecured multicurrency revolving loan facility with ICBC. The facility will be utilised for general working capital purposes and for the acquisition of investments in accordance with the Company's investment policy.

Under the terms of the facility, the Company also has the option to increase the level of the commitment from £15 million to £30 million at any time, subject to the Lender's credit approval. There was no drawdown as at the year end. On 15 December 2022, the Company utilised CNH 40,000,000 (£4.67 million) of its unsecured multicurrency revolving loan facility.

Movements in interest rates are likely to indirectly affect the value of the Company's investments.

Interest rate risk sensitivity

Movements in interest rates are likely to directly affect bank loan interest payments and commitment fees and are likely to indirectly affect the value of the Company's investments, both of which are not likely to affect the Company's net assets to a material extent. However, it is not possible to give an accurate assessment of how significant changes in interest rates would affect the prices of equity investments held by the Company.

Quantitative analysis

A breakdown of the pricing denominations of the funds in which the Company is invested is shown below.

The Company's financial assets and liabilities as at 31 October comprised:

As at 31 October 2022

As at 31 October 2021

 

Cash flow Interest rate risk £'000

 

Non interest rate risk £'000

Total £'000

% of net assets

 

Cash flow Interest rate risk £'000

 

No interest rate risk £'000

Total £'000

% of net assets

Non-current asset investments at fair value:

EUR denominated

-

-

-

-

-

-

-

-

GBP denominated

-

-

-

-

-

32,584

32,584

8.7

HKD denominated

-

91,289

91,289

39.4

-

-

-

-

CNY denominated

-

131,456

131,456

56.7

-

-

-

-

USD denominated

-

1,319

1,319

0.6

-

80,321

80,321

21.5

Cash and cash equivalents

GBP*

8,496

-

8,496

3.7

-

182,718

182,718

48.9

HKD

28

-

28

-

-

-

-

-

CNY

6

-

6

-

-

-

-

-

USD*

4

-

4

-

-

19,077

19,077

5.1

Short term receivables

-

56

56

-

-

59,957

59,957

16.0

Short term payables

(25)

(786)

(811)

(0.4)

(34)

(835)

(869)

(0.2)

 

8,509

 

223,334

 

231,843

 

100.0

 

(34)

 

373,822

 

373,788

 

100.0

* Cash held at the custodian is in a 0% interest bearing account

iv) Other price risks

The principal price risk for the Company is the price volatility on the investment portfolio. The Investment Manager attempts to diversify the price risk by spreading the Company's investments across a number of economic sectors. The Board meets regularly to review the Investment Manager's performance and the asset allocation.

Market price risk sensitivity

The effect on the portfolio of a 10% increase or decrease in market prices would have resulted in an increase or decrease of £22,406,400 (2021: £11,290,500) in the investments designated as fair value through profit or loss at the Statement of Financial Position date, equivalent to 10.0% (2021: 3.0%) of the net assets attributable to equity holders. This analysis assumes that all other variables remain constant.

Liquidity risks

A large portion of the Company's investments are in quoted securities. A high percentage of securities are listed on the Chinese, London or New York Stock Exchanges and are considered to be readily realisable by comparison with most emerging market securities. The Company also holds unquoted investments, which are predominantly in open-ended funds. The Company has made application to fully redeem its investments in unquoted and open-ended investments. Some delay may be encountered in obtaining liquidity in respect of these securities; the Company may utilise its borrowing powers on a short-term basis to avoid delays in reinvestment of the proceeds of redemptions.

The Investment Manager has estimated the percentages of the portfolio that could be liquidated within various timescales, assuming one third of daily trading volumes. The results are shown below.

Liquidation Period

2022 (%)

2021* (%)

One month

99.5

39.7

Three months

99.5

78.3

One year

99.5

95.9

The analysis above supports the Company's ability to repay borrowings, considering the Company is permitted to borrow, at the point of borrowing, up to 15% of its net assets compared to the Company's ability to realise an estimated 99% of its portfolio within one month.

The Company had £222,000 (2021: £nil) purchase transactions and £nil (2021: £59,838,000) sales transactions awaiting settlement at the year end.

The liquidity of the underlying holdings in the funds in which the Company is invested may have an impact on the ability of the Company to realise its holdings in those funds.

Credit risks

The Company's principal direct credit risk is the risk of default on cash held at the custodian. Cash at bank at 31 October 2022 included £8,534,000 (2021: £201,795,000) held by the custodian, Northern Trust (Guernsey) Limited. The Company monitors the credit quality of the custodian. Interest is based on the prevailing money market rates.

Credit risk arising on transactions with brokers relates to transactions awaiting settlement. Risk relating to unsettled transactions is considered to be low as trading is almost always done on a delivery versus payment basis. When investments are made in open-ended funds, the Investment Manager performs due diligence on those funds before making any investment.

All of the assets of the Company are held by the custodian or through the custodian's nominated sub custodians. Bankruptcy or insolvency of the Company's custodian, Northern Trust (Guernsey) Limited, or its sub custodians may cause the Company's rights with respect to securities held by them to be delayed or limited. The latest credit ratings at the time of approval of this document for Northern Trust (Guernsey) Limited's parent company, The Northern Trust Company, were as follows:

 

 

 

 

Standard & Poor's

 

Moody's

 

Fitch Ratings

 

 

Short-term/deposit

A-1+

P-1

F1+

 

 

Long-term/deposit

AA-

Aa2

AA

 

The Company's investments may be exposed to credit risk.

Capital management

The Company considers that its capital consists of its net assets.

The Company's authorised share capital consists of an unlimited number of Ordinary shares of £0.01 par value. At 31 October 2022, there were 45,283,575 (2021: 45,965,159) Ordinary shares in issue (excluding shares held in treasury).

The Manager and the Company's brokers monitor the demand for the Company's shares and the Directors review the position at Board meetings. Details on the Company's policies for issuing further shares and buying back shares can be found in the Directors' Report.

In April 2022, the Company entered into an unsecured multicurrency revolving loan facility with ICBC. The facility will be utilised for general working capital purposes and for the acquisition of investments in accordance with the Company's investment policy.

Under the terms of the facility, the Company also has the option to increase the level of the commitment from £15 million to £30 million at any time, subject to the Lender's credit approval. There was no drawdown as at the year end. On 15 December 2022, the Company utilised CNH 40,000,000 (£4.67 million) of its unsecured multicurrency revolving loan facility.

Restrictions imposed by ICBC in connection with the loan facility include the following financial covenants.

The Company shall ensure that:

• Total borrowings do not exceed 20% if the total assets at any time. ·

Its NAV shall at all times be a minimum of £200,000,000; and

The aggregate value of the unlisted investments does not exceed 10% of the aggregate value of the investments at any time.

The Company does not have any externally imposed capital requirements other than disclosed above.

Operational risk

Operational risk is the risk of direct or indirect loss arising from a wide variety of causes associated with the processes, technology and infrastructure supporting the Company's activities with financial instruments either internally within the Company or externally at the Company's service providers, and from external factors other than credit, market and liquidity risks such as those arising from legal and regulatory requirements and generally accepted standards of investment management behaviour.

The Company's objective is to manage operational risk so as to balance limiting of financial losses and damage to its reputation with achieving its investment objective of generating returns to investors.

The primary responsibility for the development and implementation of controls over operational risk rests with the Board of Directors. This responsibility is supported by the development of overall standards for the management of operational risk, which encompasses the controls and processes at the service providers and the establishment of service levels with the service providers, in the following areas:

• requirements for appropriate segregation of duties between various functions, roles and responsibilities; ·

• requirements for the reconciliation and monitoring of transactions; ·

• compliance with regulatory and other legal requirements; ·

• documentation of controls and procedures;

requirements for the periodic assessment of operational risk faced, and the adequacy of controls and procedures to address the risks identified;

• contingency plans;

• ethical business standards;

• insurance; and

risk mitigation.

The Directors' assessment over the adequacy of the controls and processes in place at the service providers with respect to operational risk is carried out via regular discussions with the main service providers to the Company and a review of their internal controls documents prepared under industry recognised guidance, if available.

18. Valuation of financial instruments

The Company's financial assets and liabilities held at fair value through profit or loss are valued at fair value in accordance with the provisions of IFRS as described in note 2 (g).

The classification of the Company's investments held at fair value is detailed in the table below:

31 October 2022 £'000

31 October 2021 £'000

Level 1

222,745

69,419

Level 2

-

42,128

Level 3

1,319

1,358

Total

 

224,064

 

112,905

The Company recognises transfers between levels of fair value hierarchy at the date the change occurred.

There were no investments transferred between levels during the year (2021: no investments transferred between levels during the year).

Level 1 classification basis

Investments, whose values are based on quoted market prices in active markets, and therefore classified within level 1, include listed equities in active markets. The Company does not adjust the quoted price for these instruments.

Level 2 classification basis

Investments that trade in markets that are not considered to be active but are valued based on quoted market prices, dealer quotations or alternative pricing sources supported by observable inputs are classified within level 2. These include monthly priced investment funds. The underlying net asset values of the open ended funds included under level 2 are prepared using industry accepted standards and the funds have a history of accepting and redeeming funds on a regular basis at net asset value. The net asset values of regularly traded open ended funds are considered to be reasonable estimates of the fair values of those investments and such investments are therefore classified within level 2 if they do not meet the criteria for inclusion in level 1.

Level 3 classification basis

Investments classified within level 3 have significant unobservable inputs, as they trade infrequently. The level 3 figure consists of an investment in Komodo Fund which is valued at the unadjusted net asset values provided by the administrator of that fund.

The movement on the level 3 classified investments during the year is shown below:

2022

2021

 

£'000

 

£'000

Opening balance

 

1,358

 

2,129

Additions during the year

-

-

Disposals during the year

-

-

Profit or loss on disposals during the year

-

-

Transfer of investment from level 2 to level 3

-

-

Valuation adjustments*

(39)

(771)

Closing balance at 31 October

 

1,319

 

1,358

* Total gains/(losses) included in profit or loss on assets held at year end.

Level 3 classified investments sensitivity analysis

If the fair value of level 3 classified investments changed by 5%, the impact on the Company's net assets attributable to equity holders would be 0.03% (2021: 0.01%). As at 31 October 2022, the Company's net assets attributable to equity holders would be adversely affected by a maximum of 0.6% (2021: 0.3%) if level 3 classified investments were written off to £nil.

Structured entities

The Company had invested in a portfolio of funds and products which gave diversified exposure to developing and emerging market economies. The Company does not consider those investments in listed funds to be structured entities but does consider those investments in unlisted funds to be investments in structured entities because the voting rights in such entities are limited to administrative tasks and are not the dominant factor in deciding who controls those entities.

The investments in structured entities are subject to the terms and conditions of offering documents and/or constitutional documents. These investments are subject to market price and other risks arising from their underlying portfolios. Investee funds are managed by portfolio managers who are compensated by the respective funds for their services. Such compensation generally may consist of an asset based fee and/or a performance based fee.

The investments in structured entities are financial assets which are designated as fair value through profit or loss in the Company's financial statements. During the year ended 31 October 2022, the Fund did not provide financial support to unconsolidated structured entities and has no intention of providing financial or other support.

The exposure to investments in investee funds and products at fair value by strategy employed is disclosed in the following table.

2022

Strategy

Number of investee funds

Fair value range £'000

Weighted average fair value £'000

Investment at fair value £'000

% of total net assets of underlying funds

Equity long-only

1

1,319

1,319

1,319

0.6%

2021

Strategy

 

Number of investee funds

 

Fair value range £'000

 

Weighted average fair value £'000

 

Investment at fair value £'000

 

% of total net assets of underlying funds

Equity long-only

5

1,358 - 16,282

13,081

51,141

45.3%

Equity long-only

Portfolio managers implementing equity long-only strategies generally take long positions in equity related instruments such as ordinary shares, preferred shares, convertible bonds, depositary receipts, exchange traded funds and market access products such as index futures with the expectation that the asset will rise in value.

19. Operating segments

The Board of Directors is responsible for ensuring that the Company's objective and investment strategy is followed. The Company's objective is to produce long-term capital growth by investing predominantly in Chinese equities across a number

of economic sectors. The day-to-day operation of the investment strategy has been delegated to the Investment Manager but the Board retains responsibility for the overall direction of the Company. The Board reviews the investment decisions of the Investment Manager at regular Board meetings to ensure compliance with the investment strategy and to assess the achievement of the Company's objective. The Investment Manager has been given full authority to make investment decisions on behalf of the Company in accordance with the investment strategy and analyses markets within a framework of quality, value, growth and change. The investment policy employed by the Investment Manager ensures that diversification within investee funds is taken into account when deciding on the size of each investment so the Company's exposure to any one underlying company should never be excessive. The Company's positions are monitored as a whole by the Board in monthly portfolio valuations and at Board meetings. Any significant change to the Company's investment strategy requires shareholder approval.

No single investment accounted for more than 7.0% (2021: 5.8%) of the Company's net assets at the Company's year end. The Investment Manager aims to identify funds which it considers are likely to deliver consistent capital growth over the longer term.

20. Post balance sheet events

Change of Company Secretary, Administrator, Depositary and Custodian

Following the end of the Financial Year, the Company has signed agreements with abrdn plc and various entities within BNP Paribas S.A. ("BNPP") to take on the various functions in due course. BNPP will become the Company's administrator and provide custody and depositary services. abrdn will take on Company Secretarial responsibilities.

Purchase of own shares

In addition to the Scheme mentioned above, since the year ended 31 October 2022, the Company has purchased 1,268,709 of its own Ordinary shares and held them in Treasury.

Loan facility draw down

Since the financial year ended the Investment Manager has drawn down a total of CNH 106m (£12.7m) in two tranches.

Interim dividend declaration in respect of the year ended 31 October 2022

Ensuring that the Company retains its investment trust status, the Board declares an interim dividend in respect of the year ended 31 October 2022 of 3.2p per Ordinary share which will be payable to Shareholders on 17 March 2023 with an associated ex-dividend date of 23 February 2023.

21. Taxation

(a) Analysis of charge :

 

Year ended 31 October 2022

 

 

 

Revenue

£'000

Capital

£'000

 

Total

£'000

 

 

Withholding tax expense

215

-

215

 

 

Total tax charge for the year

 

215

 

-

 

215

 

(b) Factors affecting the tax charge for the year:

The effective UK corporation tax rate for the year is 19% . The tax charge differs from the charge resulting from applying the standard rate of UK corporation tax for an investment trust company. The differences are explained below:

Year ended 31 October 2022

 

 

 

Revenue

£'000

Capital

£'000

 

Total

£'000

Operating profit before taxation

 

2,066

 

(142,805)

 

(140,739)

UK Corporation tax at 19%

393

(27,133)

(26,740)

Effects of:

Withholding tax expense

215

-

215

UK dividends not taxable

(769)

-

(769)

Capital gains/(losses) not subject to tax

-

27,133

27,133

Overseas dividends not taxable

(3)

-

(3)

Other Income not taxable

(8)

-

(8)

Finance costs not tax deductible

21

-

21

Movement in unutilised management expenses

366

-

366

Total tax charge

 

215

 

-

 

215

No deffered tax asset has been recognised in the accounts because, given the composition of the Company's portfolio, it is unlikely that a deffered tax asset will be utilised in the foreseeable future. The Company has not provided for deferred tax on any tax losses.

ACIC received approval by HMRC to be classified as an investment trust under Chapter 4 of Part 24 CTA 2010 and Chapter 1 of Part 2 of The Investment Trust Tax Regulations. As a result, the Company became an investment trust with effect from 9 November 2021 and is registered in the United Kingdom for tax purposes from that date. No tax computation is required in respect of the prior year ended 31 October 2021.

 

 

 

 

Alternative Performance Measures ("APMs") (unaudited)

Discount

The amount, expressed as a percentage, by which the share price is less than the NAV per Ordinary share.

As at31 October 2022

As at31 October 2021

NAV per Ordinary share (pence)

a

511.98

813.20

Ordinary share price (pence)

b

448.00

695.00

Discount

1-(b÷a)

 

12.5%

 

14.5%

Gearing

The net gearing ratio is calculated by dividing total borrowings less net liquid cash by Shareholders' funds and expressing the result as a percentage. Under AIC reporting guidance cash and cash equivalents includes the value of purchases and sales for future settlement at the period end as well as cash.

As at31 October 2022£'000

As at31 October 2021£'000

Total borrowings

a

-

-

Cash and bank

8,534

201,795

Sales for future settlement

-

59,838

Purchases for future settlement

-222

-

Cash and cash equivalents

b

8,312

261,633

Gearing (borrowings less cash and cash equivalents)

c=(a-b)

-8,312

-261,633

Shareholders' funds

d

231,843

373,788

Net (cash) / gearing

c/d

 

-3.60%

 

-70.00%

Leverage

Under the Alternative Investment Fund Managers Directive ("AIFMD"), leverage is any method by which the exposure of an Alternative Investment Fund ("AIF") is increased through borrowing of cash or securities or leverage embedded in derivative positions.

Under AIFMD, leverage is broadly similar to gearing, but is expressed as a ratio between the assets (excluding borrowings) and the net assets (after taking account of borrowing). Under the gross method, exposure represents the sum of the Company's positions after deduction of cash balances, without taking account of any hedging or netting arrangements. Under the commitment method, exposure is calculated without the deduction of cash balances and after certain hedging and netting positions are offset against each other.

Further details on the Company's leverage is provided in the Annual Report for the Financial Year ended 31 October 2022.

Ongoing charges

A measure, expressed as a percentage of average NAV, of the regular, recurring annual costs of running an investment company.

As at31 October 2022

As at31 October 2021

Average NAV (£'000)

a

319,519

372,698

Annualised expenses* (£'000)

b

1,933

3,635

Ongoing charges

b÷a

 

 

0.60%

 

0.98%

*100% of the Company's portfolio is held in other funds. The Company's ongoing charges figure does not reflect any costs of the underlying funds as the underlying information is not readily available.

Total return

A measure of performance that includes both income and capital returns. This takes into account capital gains and reinvestment of dividends paid out by the Company into its Ordinary shares on the ex-dividend date.

Year ended 31 October 2022

 

Ordinaryshare price

NAV

Opening at 1 November 2021 (pence)

a

695.00

813.20

Closing at 31 October 2022 (pence)

b

448.00

511.98

Share price/NAV movement (b ÷ a) - 1

c

-35.5%

-37.0%

Dividend reinvestment

d

0.0%

0.0%

Total return (c+d)

 

-35.5%

 

-37.0%

n/a = not applicable

Year ended 31 October 2021

 

Ordinaryshare price

NAV

Opening at 1 November 2020 (pence)

a

605.00

698.29

Closing at 31 October 2021 (pence)

b

695.00

813.20

Share price/NAV movement (b ÷ a) - 1

c

14.9%

16.5%

Dividend reinvestment

d

3.8%

3.3%

Total return (c+d)

 

18.7%

 

19.8%

n/a = not applicable

 

 

Additional Notes to the Annual Financial Report

The Annual General Meeting will be held at Wallacespace Spitalfields, 15-25 Artillery Lane, London, E1 7HA at 12 noon on 13 April 2023.

The Annual Financial Report Announcement is not the Company's statutory accounts. The above results for the year ended 31 October 2022 have been agreed with the auditor and are an abridged version of the Company's full accounts, which have been approved and audited with an unqualified report. The 2021 and 2022 statutory accounts received unqualified reports from the Company's auditor and did not include any reference to matters to which the auditor drew attention by way of emphasis without qualifying the reports, and did not contain a statement under s.498(2) or 498(3) of the Companies Act 2006. The financial information for 2021 is derived from the statutory accounts for 2021 which have been delivered to the Registrar of Companies. The 2022 accounts will be filed with the Registrar of Companies in due course.

 

The Annual Report and Accounts will be posted to shareholders in February 2023. Copies will be available during normal business hours from the Secretary, Vistra Fund Services (Guernsey) Limited, 11 New Street, St Peter Port, Guernsey GY1 2PF or from the Company's website, www.abrdnchina.com. It will also be submitted to the National Storage Mechanism where it will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Please note that past performance is not necessarily a guide to the future and that the value of investments and the income from them may fall as well as rise and may be affected by exchange rate movements. Investors may not get back the amount they originally invested.

By order of the Board

 

Vistra Fund Services (Guernsey) Limited

Company Secretary

 13 February 2023

 

Aberdeen Standard Fund Managers Limited will be hosting an Online Shareholder Presentation, which will be held at 10.00am on 30 March 2023. Full details on how to register for the online event can be found at:

https://bit.ly/abrdn-China-webinar

 

Enquiries:

 

abrdn Fund Managers Limited (Alternative Investment Fund Manager to the Company)

Evan Bruce-Gardyne Tel: +44 (0)7720 073216

 

Shore Capital Markets Limited (Financial adviser and stockbroker)

Robert Finlay Tel: +44 (0)777 176 5675

 

Ordinary Shares - Listing Category: Premium - Equity Closed-ended Investment Funds

 

 

* Neither the content of the Company's website nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

 

13 February 2023

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR NKNBNKBKBOBD
Date   Source Headline
11th Mar 202411:30 amRNSResult of First General Meeting
8th Mar 20242:44 pmRNSResult of Elections
7th Mar 202412:36 pmRNSNet Asset Value(s)
7th Mar 20247:30 amRNSSuspension-Abrdn China Investment Company Limited
6th Mar 20245:25 pmRNSMonth End Net Asset Value(s)
6th Mar 202411:47 amRNSNet Asset Value(s)
5th Mar 202412:41 pmRNSNet Asset Value(s)
4th Mar 20242:18 pmRNSGearing disclosure
4th Mar 202412:13 pmRNSNet Asset Value(s)
1st Mar 202410:00 amRNSDoc re. Annual Report
29th Feb 202412:55 pmRNSNet Asset Value(s)
28th Feb 202411:33 amRNSNet Asset Value(s)
27th Feb 202412:46 pmRNSNet Asset Value(s)
26th Feb 20245:36 pmRNSGearing Disclosures
26th Feb 202412:42 pmRNSNet Asset Value(s)
23rd Feb 202412:21 pmRNSNet Asset Value(s)
22nd Feb 202412:44 pmRNSNet Asset Value(s)
21st Feb 202412:48 pmRNSNet Asset Value(s)
20th Feb 202412:36 pmRNSNet Asset Value(s)
19th Feb 202412:50 pmRNSGearing disclosure
19th Feb 202411:56 amRNSNet Asset Value(s)
16th Feb 20244:05 pmRNSAnnual Financial Report
16th Feb 20244:00 pmRNSPublication of Circular
16th Feb 202412:35 pmRNSNet Asset Value(s)
15th Feb 202411:06 amRNSNet Asset Value(s)
14th Feb 202412:36 pmRNSNet Asset Value(s)
14th Feb 202410:41 amRNSPortfolio Disclosures
13th Feb 202412:22 pmRNSNet Asset Value(s)
9th Feb 202412:34 pmRNSNet Asset Value(s)
8th Feb 202411:53 amRNSNet Asset Value(s)
7th Feb 20241:12 pmRNSNet Asset Value(s)
7th Feb 202411:18 amRNSMonth End Net Asset Value(s)
6th Feb 202412:12 pmRNSNet Asset Value(s)
5th Feb 20244:01 pmRNSGearing disclosure
5th Feb 202412:14 pmRNSNet Asset Value(s)
2nd Feb 20244:00 pmRNSQuarterly disclosure
2nd Feb 202412:36 pmRNSNet Asset Value(s)
31st Jan 202412:39 pmRNSNet Asset Value(s)
30th Jan 202411:52 amRNSNet Asset Value(s)
29th Jan 20242:07 pmRNSGearing disclosure
29th Jan 202411:53 amRNSNet Asset Value(s)
26th Jan 202412:17 pmRNSNet Asset Value(s)
25th Jan 202412:24 pmRNSNet Asset Value(s)
24th Jan 202412:36 pmRNSNet Asset Value(s)
23rd Jan 202412:15 pmRNSNet Asset Value(s)
22nd Jan 20242:02 pmRNSGearing disclosure
22nd Jan 202411:51 amRNSNet Asset Value(s)
19th Jan 202411:22 amRNSNet Asset Value(s)
18th Jan 202410:58 amRNSNet Asset Value(s)
17th Jan 202411:59 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.